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Metalloenzymes catalyze various reactions and in particular dioxygenases 
insert dioxygen into organic substrates. Since these enzymes usually utilize 
histidines as ligands for the metal cofactor, we focused our attention on the 3-
His-1-carboxylate binding motif as it has been shown recently to be a common 
feature of the cupin superfamily. Most structural and functional models studied 
substitute the imidazole rings by pyrazoles, pyridines and alkyl amines to 
simplify the synthetic challenge. However, the different donor/acceptor 
properties and basicity of imidazole render these models inaccurate. We therefore 
developed the synthesis of imidazole-containing ligand mimics of the 3-His-1-
carboxylate motif. The synthesis of the known tris[(4)-imidazolyl]carbinol, 4-TIC 
31, a mimic of the 3-His binding motif, was improved and optimized making this 
ligand now easily accessible on gram scale. This access allowed us to 
characterize its 2:1 complex with iron (III) 52 by X-ray crystallography, the first 
crystal structure of a metal complex incorporating 4-TIC. 
Moreover, we also report the synthesis of a functionalized mixed tripodal 
unit bearing a short side-chain 73. Its coordination chemistry has been explored 
and a 2:1 cobalt complex was prepared and characterized by X-ray 
crystallography 104. The coordination properties of the ligand can be described 
as an N2O-donor. We also expanded the synthetic route to incorporate an 
extended side-chain onto a mixed tripodal unit 106. However, the coordination 
chemistry was difficult due to the low solubility of the ligands in polar aprotic 
organic solvents and its propensity to form intractable solids when mixed with 
metal ions. We thus optimized the ligand design and synthesized 105 with a N3O 
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binding mode with Cu (II) and characterized complex 129 by X-ray 
crystallography. Complex 129 is the first structural model complex of the 2,3-
quercetin dioxygenase incorporating all three imidzoles and a carboxylate 











The selective oxidation of hydrocarbons, a thermodynamically favored but 
kinetically disfavored process, is catalyzed by many enzymes via dioxygen 
activation. Most enzymes utilize a metal cofactor in order to circumvent the spin 
forbidden process of reacting molecular oxygen in a triplet state with organic 
substrates. The metal cofactor, with an open-shell electronic structure, can directly 
activate/reduce dioxygen by its coordination or activate the substrate leading to the 
formation of some radical character on the reactant, which can then react with O2. 
The binding of the metal cofactor is often achieved by poly-histidinyl motifs, and 
the 2-His-1-carboxylate triad is generally considered to be the canonical motif of 
mononuclear nonheme iron oxygenases.1,2 However, rather than a general motif, it 
has recently been revised as a subset of a much larger binding mode observed in the 
cupin superfamily.3 Based on primary structure homology and tertiary structure, 
one can regroup enzymes into a superfamily displaying a given number of 
commonalities. These structurally related proteins found in plants, microbes and 
higher organisms seem to exhibit two highly conserved motifs: 
G(X)5HXH(X)3,4E(X)6G and G(X)5PXG(X)2H(X)3N. The first β-strand contains 
two histidines and a glutamic acid residue which are complemented by a third 
histidine from the second β-strand, thus providing as a whole a recurring metal 
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binding site throughout the cupin superfamily.4 The 2-His-1-carboxylate triad can 
then be derived by replacing one the histidines of the first strand by Gln or 
Asp/Glu.5 The existence of the cupin superfamily was hypothesized and confirmed 
by the study of germin and germin-like proteins (GLP). The cupin functions are 
multiple and display a wide array of activities such as isomerization and 
epimerization. Germin, an archetypal representative of the cupin superfamily,6 
possesses a MnII center with oxalate oxidase7,8 and superoxide dismutase (SOD) 
activities. Germin’s active site Mn is octahedral with the His2GluHis tetrad 
coordinating bi-facially, as determined by X-ray crystallography. This mode of 
coordination is very different from the classical Mn-SODs, which do not have a 
trans carboxylate ligand to histidine.9 This coordination specificity was further 
corroborated by structures of Barley oxalate oxidase,10 and a manganese dioxygen-
dependent oxalate decarboxylase from Bacillus subtilis.11,12 
Since we were interested in emulating the unusual reactivity of 
metalloenzymes by developing biomimetic catalysts and exploring accurate mimics 
of the important recurring 3-His-1-carboxylate binding mode, we focused our 
attention on dioxygenases known to activate and insert dioxygen into organic 
substrates. In the next sections we will detail structures, mechanisms and model 
studies of three enzymes: 1) quercetin 2,3-dioxygenases, 2) acireductone 
dioxygenases, both from the cupin superfamily, and 3) the important lipoxygenases 
which also display the 3-His-1-carboxylate tetrad and have recently attracted the 
attention of bioinorganic chemists. Spectroscopic and functional models of these 
poly-histidinyl metalloenzymes have been developed, though very few incorporate 
poly-imidazole ligand sets. Our work will expand the known models by utilizing 
imidazole ligands as accurate mimics of histidines. We will develop in the second 
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chapter our efforts in integrating them into the synthesis of a 3-His-1-carboxylate 
mimic. We initially improved the synthesis of the known tris[4(5)-imidazolyl] 
carbinol (4-TIC) ligand and investigated its coordination properties with iron (III) 
as a 3-His mimic. We further investigated the functionalization of 4-TIC and 
discovered that the carbinol carbon was prone to substitution reactions under acidic 
conditions. We will also detail our effrorts to incorporate the carboxylate moiety 
into the tripodal unit and report on the coordination properties of two different 3-
imidazole-1-carboxylate ligands. The results obtained allowed us to prop se a new 
ligand design and to synthesize a copper (II) complex with a tetradent te N3O-
donor ligand. This complex is the first structural model of copper-dependent 
quercetin 2,3-dioxygenase utilizing only imidazoles as nitrogen-donors and a 
carboxylate side-chain. 
 
1.2 Cu-dependent quercetin 2,3-dioxygenases 
1.2.1 Introduction and background 
Quercetin 2,3-dioxygenases catalyze the oxygenolysis of two carbon-carbon 
bonds in quercetin 1 (scheme 1.1) by a metal-promoted insertion of dioxygen. This 
reaction, calculated to be 88.9 kcal/mol exothermic,13 is only reproducible in the 
laboratory under harsh conditions,14 illustrating the kinetic inertness of triplet 
oxygen with organic substrates. Fungi, known to survive on these typesof 
substrates as a sole source of carbon and energy, utilize quercetinases to catalyze 
the reaction of dioxygen and quercetin 1 yielding 2-(3,4-dihydroxy-benzoyloxy)-


















1 2  
Scheme 1.1 
 
Quercetin 2,3-dioxygenases have been isolated with different metals, for exampl: 
i) Quercetin 2,3-dioxygenase from Bacillus subtilis was initially isolated as an Fe2+ 
containing enzyme15,16 but is active with a wide variety of metals: Mn2+, Co2+, Ni2+, 
Cu2+. As iron (II) fails to fully restore the apo-protein17 manganese (II) is 
considered to be the native metal cofactor.18 
ii) Quercetinase QueD of Streptomyces p. FLA exhibits a preference for cobalt (II) 
and nickel (II).19 
iii) Quercetin 2,3-dioxygenase from Aspergillus japonicus is a copper (II)-
containing quercetinase. The copper (II)-dependent quercetinases’ active site 
structure and mechanism is well studied and model complexes in biomimetic 
reactions are reviewed in details within the next section. 
 
1.2.2 Structure 
The presence of copper (II) in quercetin 2,3-dioxygenases has been 
definitively demonstrated20,21 and extensively characterized in quercetinase from 
Aspergillus niger, for example.22 The crystal structure of quercetin 2,3-dioxygenase 
from Aspergillus japonicus was solved at 1.6 Å resolution and reported as a dimer 
displaying two type 2 mononuclear copper centers (figure 1.1). The first center has 
a distorted tetrahedral coordination environment with three histidines and a water 
around copper (II), representing approximately 70% of the conformations. A minor 
conformation shows a glutamic acid coordinated to the copper center, forming a 
trigonal bipyramidal structure, with three histidines and the glutamate coordinated
(the first carboxylate ligand observed in natural copper
heterogeneous environment is also found in solution
 




quercetin in its active site, allowing
the enzyme and its native 
quercetin leads to a single 
EXAFS (Extended X
coordination to copper 
confirmed by X-ray structure 





Cu-dependent 2,3-quercetin dioxygenase active site 




dioxygenase from Aspergillus japonicus was crystallized with 
 the detection of potential interaction
substrate. The displacement of a molecule of water by 
penta-coordinated copper center as demonstrated by 
-ray Absorption Fine Structure).24 Quercetin monodentate 
through its C3 hydroxyl group (C3-OH) 
and the newly formed complex is square pyramidal 










also noticeable, as carbon C2 is pyramidalized (scheme 1.2), thus increasing its sp3 
character and potentially promoting a carbon-centered radical mechanism. 
Moreover the coordinated glutamate (Glu-Cu= 2.55 Å) is within hydrogen bond 
distance to the 3-hydroxy group of quercetin. From these observations the proposed 
mechanism of the reaction is initiated by a glutamate mediated deprotonation of 
quercetin, glutamic acid maintaining the proton at proximity until the final step 
(scheme 1.2). This initial step is supported by: 1) a deflation of the pKa upon 
copper binding (flavonol is partially deprotonated at pH= 7 in water), and 2) the 

































The second step invoked is a valence tautomerism of 3 t  3-taut (scheme 1.3), in 
order to circumvent the spin forbidden process.25 It consists of the transfer of a 
single electron from the substrate to copper, thus producing a CuI–flavonoxyl 
radical, though it was not detected by EXAFS (Extended X-ray Absorption Fine 
Structure).24 The radical centered on C2 of quercetin 3-taut is directly attacked by 
dioxygen, which diffuses to the active site through a putative hydrophobic channel 







































An alternative mechanism, wherein dioxygen is initially activated by copper (I) has 
been proposed based on gas phase calculations,13 but analysis of O2 activation by a 
copper (I)-substrate radical was not supported by modeling studies in the enzyme’s 
active site, and an intradiol type mechanism is favored.27,28 The following step 



































The intermediate 5 decomposes to the desired compound 6 and the proton, removed 
in the first step, is transferred back to product 6 to give 2. 
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1.2.4 Structural and functional models 
Structural and functional model complexes have been synthesized and 
studied for quite some time, as they could potentially provide insight into enzyme 
catalysis, but also as potential catalyst for bioremediation of aromatic and 
heteroaromatic waste products. Copper complexes catalyze the reaction of 
dioxygen with flavonol or quercetin.29-32 The first fully characterized functional 
model of quercetin 2,3-dioxygenase is Cu(PPh3)2fla 7 (fla= flavonolate anion) 7 
(scheme 1.5). The tetrahedral copper (I) complex is competent in the oxygenolysis 
of flavonolate and shown to correctly incorporate labeled dioxygen and release 
carbon monoxide. This reaction likely proceeds via dioxygen activation by a CuI 
center.33 The 1,3-bis(2-pyridylimino)isoindoline (IndH) ligand 8 (scheme 1.5) was 










7 8  
Scheme 1.5 
 
The most relevant copper (II) complex, 9, incorporating a N3O-donor set, is a 
functional model with a moderate turnover rate of 6 per hour at 90 °C in DMF 
(scheme 1.6).36 Interestingly external carboxylate ligands have been reported 


















The structural models, including 7-9, are very approximate, which is 
reflected in the lack of a good spectroscopic model of the enzyme’s active site. The 
critical steps of the mechanism have not been addressed by the model chemistries 
and a better understanding of the regioselectivity of the electrophilic attack by 
dioxygen is necessary. Ultimately any single model might not be able to fully 
explain the regioselectivity as the mechanism in bulk solvent is likely to differ 
greatly from the enzymatic one. Also the selectivity of the 1,2 versus the 1,3 
addition of dioxygen on the quercetin core is also intriguing as the 1,2 addition, not 
leading to the desired products, was calculated to be energetically favorable. The 
functional models are competent but a lot of room remains for improvements, as the 
reaction was limited to DMF and high temperatures were required (70 to 100 °C).29-
36 
 
1.3 Acireductone Dioxygenase 
1.3.1 Introduction and background 
In the methionine salvage pathway, the penultimate step is the 
dioxygenation of acireductone by AciReductone Dioxygenase (ARD’). Two 
10 
 
monomeric forms exist and share the same polypeptide chain but differ in their 
metal content. Iron (II) and nickel (II) impart very different physical and chemical 
properties to the protein, and either enzymatic activity could be reconstituted from 
the apo-protein by incubation with the appropriate metal. They were 
chromatographically separated and have distinct catalytic activity. 
ARD’, an iron (II) containing enzyme, catalyzes an on-pathway 1,2 
oxygenolytic decomposition of acireductone, 10 to yield the α-keto acid precursor 
11 to methionine (scheme 1.7). Dioxygen labeling proved the incorporation of both 
oxygen atoms into the formate and the keto-acid products.39 The enzyme could still 














10 11  
Scheme 1.7 
 
The nickel (II)-containing protein ARD catalyze an off-pathway reaction, 
via a 1,3 oxygenolysis, producing 3-methyl thiopropionate, 12, formate and carbon 
monoxide (scheme 1.8).40,42,43 The enzyme’s activity was conserved when nickel 
was replaced by Mn2+ and Co2+, albeit with a lower activity. Labeling studies with 






















The nickel and iron containing enzymes seem to possess approximately the 
same octahedral coordination with exactly the same ligands. Both use the same 
residues of the polypeptide chain, three histidines and a glutamate in  pseudo 
octahedral environment, with one or two unknown remaining ligands. 
The structure of ARD from Klebsiella ATCC 8724 was determined in 
solution by NMR experiments, and is consistent with a Ni2+ center coordinated by 
the cupin superfamily motif: 2-His-Glu-His.44-46 The structure was further refined 
and confirmed by XAS (X-ray Absorption Spectroscopy) to obtain a clearer picture 
of the paramagnetic nickel (II) coordination. EXAFS analysis points to 3 or 4 His 
and 2 or 3 other O/N ligands.47,48 
ARD’ coordination environment was determined by XAS including EXAFS 
and XANES (X-ray Absorption Near Edge Spectroscopy) which also support an 
octahedral geometry.49 
A partial structure of a related ARD or ARD’ (metal unknown) from Mus 
musculus has been resolved by X-ray crystallography, but two ligands on the metal 




1.3.3 Catalytic mechanism 
XAS analysis of substrate binding in both enzymes supports the 
displacement of two ligands one of which is thought to be a histidine.47,48,51 The 
mechanisms of ARD and ARD’ were probed by using a monoanionic desthio 
analogue, 13 (λmax= 305 nm, ε= 20000 M
-1 cm-1, pKa1= 4.0 and pKa2= 12.2; 
scheme 1.9)52 binding the metal center as a dianionic ligand causing a similar shift 
in the λmax for both enzymes (λmax= 345 nm, ε= 14000 M
-1 cm-1). Moreover, a 
cyclopropyl analogue 14 inhibited both enzymes under aerobic conditions. Based 












The apparent metal-guided selectivity is tentatively rationalized by the 
pocket’s size and shape of the active site, which is subtly controlled by the metal 
coordination. The iron containing enzyme allows for an extended substrate 
conformation (figure 1.2 and scheme 1.10) and thus a 1,2 coordination of the 
substrate, 10 (5 membered chelate), is hypothesized prior to an electron transfer to 
O2. In the nickel form, bulk within the pocket enforces a 1,3 coordination of 10 


















































Recombination of the radicals produces peroxide, 15 or 16, that either attacks in a 
1,2 fashion, in the case of a 5 membered ring chelate to form 17, or in a 1,3 fashion 
for a six membered ring chelate to form 18 (scheme 1.11). Both intermediates lead 







































1.3.4 Structural and functional complexes 
Octahedral Ni(II) complexes containing four nitrogen donors were 
synthesized and characterized by X-ray crystallography and their solution structure 
confirmed by NMR spectroscopy and conductance.53 These complexes are 
primarily based on aryl-appended tris((2-pyridyl)methyl)amine ligands which have 
been very successful in coordination chemistry.54 The first and excellent functional 
model of Ni ARD was produced by L. M. Berreau who characterized a mixed 



































The X-ray structure showed symmetrical bidentate binding of the substrate through 
O1 and O3, diagnostic of a fully delocalized anion. The absorption spectrum 
displayed a λmax= 399 nm and ε= 2400 M
-1 cm-1. Upon addition of one equivalent 
of base a shift in the absorption was observed (λmax= 420 nm and ε= 2500 M
-1 cm-1) 
and labeling studies showed incorporation of oxygen atoms at C1 and C3 from 
dioxygen to yield the complexed carboxylic acids 20 and carbon monoxide.55,56 
 
Conclusion 
The study of biomimetic Ni-ARD complexes is an emerging new field 
which should lead to a better understanding of the enzyme’s mechanism. The work 
done by L. M. Berreau is a good example on how a model complex can give 
important insights into the enzymatic reaction. The coordination mode of the model 
substrate led to a refined mechanism by biochemists and further studies of these 
complexes should reveal even more details. Important points remain to be 
addressed via concerted efforts on the biochemical and small molecule modeling 
fronts. A definitive identification of the displaced ligands would further our 
understanding of the enzymatic reaction. A comparison of the acid-b se reaction in 
copper-dependent quercetinase is interesting, as the deprotonation of the 
monoanionic acireductone, much more difficult than neutral quercetin, may require 
histidine, a stronger base than glutamate. This scenario is con istent with 
experimental observations. The second step is also dramatically different from 
copper quercetinase where no valence tautomerism is considered, and a radical 
superoxide has been implicated. The low oxidation state of iron and the redox




1.4.1 Introduction and background 
Lipoxygenases are mononuclear non-heme iron enzymes catalyzing the 
regiospecific and stereospecific insertion of dioxygen into fatty cids. These 
dioxygenases are found in mammals, higher plants and even fungi. Their isolation 
and implication in the inflammatory response57 and cancer growth regulation in 
humans led to an increased effort in the elucidation of their structures and their 
mechanisms of action.58 The arachidonic acid cascade is essentially divided into 
two pathways (scheme 1.13): 1) the cyclooxygenase pathway which leads to the 
production of prostaglandins (not shown) and 2) the lipoxygenase pathway 
involved in the synthesis of lipoxins and leukotrienes. These primary metabolites 
are implicated in vaso and broncho-constriction and granulocyte chemotaxis.59 
Leukotrienes are synthesized from arachidonic acid by insertion of dioxygen to the 
C5 position by 5-Human Lipoxygenases (5-HLO) which are denominated by the 
position activated on the arachidonic acid skeleton; whereas lipoxins are formed by 
insertion of dioxygen to C15 and C5 by respectively 15-HLO and 5-HLO. 12-HLOs 
















The soybean lipoxygenases (SLO) are isolated and purified from soybean 
seeds, where they are found in high concentration. To date three different o ms 
have been isolated: SLO-1, SLO-2 and SLO-3. SLOs have been implicated in 
growth regulation, wound repair, and pest resistance. They also showome 
antimicrobial and antifungal activity.61 SLOs are water soluble globular enzymes 
and possess a single polypeptide.62 The stability and ease of purification of soybean 
lipoxygenase-1 (SLO-1) has made it a representative model of the whole family and 
by extension a model enzyme for the mammalian lipoxygenases. SLO-1 
specifically oxidizes the 1,4-diene motif of linoleic acid but was also competent in 
the catalysis of monounsaturated fatty acids yielding enones.63 
In the particular case of SLO-1, linoleic acid 21 was oxidized to 13(S)-
hydroperoxy-9,11-octadecadienoic acid (13-HPOD) 22, with the specific feature of 







21 22  
Scheme 1.14 
 
The enzyme was isolated in its ferrous state and exhibited a lag time, during which 
a non-enzymatic oxidation of the diene by dioxygen produced hydroperoxyacids, 
which have been shown to activate the enzyme by oxidizing iron (II) to iron (III).65 
The high spin ferric form, or yellow form, exhibited an axial (g~6, S= 5/2) EPR 
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signal and is a yellow chromophore (λmax= 350 nm, ε= 2000 M
-1 cm-1). This 
absorption is attributed to a charge transfer from a hydroxide ligand to iron (III).66 
Interestingly when an excess of 13-HPOD 22 was used a purple form was produced 
with a rhombic signal for its EPR spectrum.67 The enzyme is considered to be a fast 
enzyme with a kcat/Km= 3.10
7 M-1s-1,68 and multiple kinetic studies have established 
the rate limiting step of SLO-1, at temperatures greater than 32 °C, to be the 
cleavage of the doubly activated C-H bond. An unusual kinetic isotope effect was 
also reported and measured to be around 80.69-71 This unusually large kinetic 
isotope effect and its little temperature dependence raised the possibility of a 
quantum mechanical tunneling pathway which was also observed in the human 15-
HLO (KIE= 477).72 
 
1.4.2 Structure 
The structure of SLO-1 has been elucidated by X-ray crystallography (figure 
1.3).73-75 In its ferrous form a distorted octahedral active site was found, with a first 
coordination sphere composed of: 1) three histidines, His499, His504 and His 690, 
bound through their Nε2 atom 2) a terminal iso-leucine, Ile839, and 3) a molecule 
of water. A loosely bound asparagine, Asn694, at 3.0 Å from the ferrous center 
completes the first coordination sphere and enforces an octahedral g ometry (figure 
1.3). A similar crystal structure of SLO-376 is also available as well as a rabbit 15-
LOX which display four histidines, rather than an asparagine.77 
Asparagine 694 is partially coordinated to the ferrous center resulting in two 
coordination modes: five and six coordinates (5C/6C) in a ratio of approximately 
60/40. The enzyme achieves this state of loose binding by controlling the 
orientation of Asn rather than restricting its approach to the metal.78 I  is involved in 
an extended hydrogen bond network, 
mutation or addition of a low molecular weight alcohol inducing a change in the 
populations of 5/6C.79,80
hydroxide, a strong donor, with a short Fe
EXAFS.80 
 
Figure 1.3: SLO-1 active site (




been reached and is supported by experimental data and computational studies.
The initial step is the abstraction of the doubly activated allylic hydrogen 
acid 21 to form a pentadienyl radical moiety
abstraction has been calculated to be exothermic by approximately 12.6 kcal/mol. 
The iron (III) hydroxide motif is significantly different
iron center usually invoked in nonheme iron enzymes
shown to be responsible for hydrogen abstraction by kinetic studies
high FeII/III reduction potential of 0.6 V (versus hydrogen)
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which could be disrupted by single point 
 The ferric state is only a 5C center and the presence of the 
-OH bond (1.9 Å) was confirmed by 
 
waters not shown, PDB entry: 1YGE)
ater not shown.
mechanism 
81 were initially proposed, but a consensus has 
 23 (scheme 1.15).
 from the high valent oxo
, and was unambiguously 
85 and it is essential for 




83 This hydrogen 
-
.84 SLO-1 has a 
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the catalytic efficiency. Raising the E° of the couple FeII/ III  by diminishing the 
number of ligands is regarded as one of the main driving forces for the H-
abstraction step. Moreover this model was supported by the studyof mutants. 
N694H was produced and displayed an only six coordinate iron (III) center, 
histidine becoming a ligand for iron. The reduced catalytic activity is rationalized in 
terms of decreased reduction potential of the metal center.86 Another singly mutated 
lipoxygenase N694C formed an only six coordinate iron center in its oxidized form, 
further corroborating the rational.87 
According to DFT calculations, as the hydrogen atom is shifted from carbon 
to oxygen no spin density develops on any of the three collinear atoms 
involved.78,82 However, the spin density manifests itself in the diene moiety and the 
iron center lending credence to a proton coupled electron transfer mechanism, the 
electron being directly transferred from the diene to the iron (III).78 This step, 
suggested to occur via tunneling of the proton has elicited a vigorous debate in the 
literature as the role of the protein’s motions and dynamics have been a point of 
contention.88-93 
The product of the second step 24, a peroxyl radical, experimentally 
detected is the result of a direct addition of dioxygen to the pentadienyl radical. The 
calculated transition state (2 kcal/mol) is low lying and the process is exergonic by 
8 kcal/mol.82 Under thermodynamic control in solution the dioxygenation of C9, 
C11 and C13 was reversible with a preference for C1194 rather than C13, as 
observed in the enzyme. Single point mutagenesis revealed the importance of steric 
factors to the step’s regioselectivity and a channel guiding the dioxygen’s access to 
the organic substrate has therefore been proposed, thought to control the 
































The purple form, usually observed when an excess of hydroperoxide was present, is 
due to an alkylperoxo moiety coordinated end-on to the iron center, the structure of 
which has been confirmed by X-ray crystallography.97 This metastable form of 
lipoxygenase produced carbon centered and peroxyl radicals83 but also decomposed 
to regenerate the ferric form of lipoxygenase and 13-(S)-HPOD 22 also obtained 
directly from 24. 
 
1.4.4 Structural and functional complexes 
Initial reports of lipoxygenase mimics modeled the histidine facial triad with 
polypyrazolylborate ligands, structurally different and undesirably negatively 
charged.98 The synthetically challenging terminal ferric hydroxide motif presumed 
to be the catalytically relevant species, was produced by using tris-(6-
neopentylamino-2-pyridinylmethyl)amine), tnpa. The distorted octahedral 
environment of the iron (II) complex 25 (scheme 1.16) provided two factors 
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important to the stability of the complex. The steric bulk of the neopentyl unit 



























Stack and co-workers101,102 have been successful in designing an iron 
complex 26 (scheme 1.17) displaying the desired iron (III)-methoxide motif, 
mimicking the hydroxide ligand in lipoxygenases. The ligand, composed f four 
pyridines, enforced a six coordinate square pyramidal structure with little 













One of the main features of the iron (III) complex 26 was its short Fe-O bond 
(1.782(3) Å) and its large Fe-O-CH3 angle (165°) supporting the notion of multiple 
bond character between iron and oxygen. The redox potential of the high spin iron 
(III) complex was measured at 0.730 V vs. SHE. The complex abstracted hydrogen 
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atom from numerous substrate and followed kinetics consistent with a first order in 
the complex and substrate. The highest KIE measured with this complex is 6.5 with 
toluene, and a thermodynamic justification of the reaction was provided. Hydrogen 
atom abstraction reactions by organic compounds, transition metals103,104 and metal 
oxos105-107 follow the Polanyi relationship correlating the rates and activ tion 
parameters with the carbon-hydrogen bond strength. The driving force for hydrogen 
abstraction is generally reflected in the thermodynamic affinity for hydrogen, i.e. 
H+ and e-. A calculated bond dissociation energy for the FeII-HOMe of 83.52 
kcal/mol made the iron (III) competent for hydrogen atom abstraction on 1,4 
cyclohexadiene and exhibited a linear correlation between the log(kreac) and the 
bond dissociation energy (BDE).102 
A new type of manganese-dependent lipoxygenase was recently discovered 
and is mechanistically similar to SLO-1.108-110 Using the same ligand, Stack et al. 
synthesized a MnIII-OH complex which displayed the same general behavior as 26. 
A redox potential of 0.81 V was measured and a bond dissociation energy of 822 
kcal/ mol. The KIEs were lower and seemed to be less sensitive to BDE.111 This 
complex was also compared to an FeIII–OH complex obtained with a slightly 
modified ligand.112 
A closely related work done by Mayer and co-workers113-115 investigated the 
ability of iron(III) (HBim)(H2Bim)2(ClO4)2 27 (scheme 1.18) to abstract hydrogen 
atoms. The metal complex was competent and abstracted hydrogen atom from weak 
C-H bonds. The formation of an N-H bond estimated at 762 kcal/mol was the 






































Lipoxygenases are fascinating enzymes and the hydrogen atom abstraction 
step has elicited an intensive and fruitful research in biochemistry, small molecule 
mimics and computational chemistry. However, the models studied did not utilize 
biologically accurate ligand sets and used mainly pyridines as sub titutes for 
histidines. One of the major features of lipoxygenases not reproduced by models are 
the very large kinetic isotope effects, but structural models have reproduced the 
spectroscopic signatures of lipoxygenases and functional models have benefitted 
from a firmer reframed theoretical ground. 
 
1.5 Conclusion 
The three specific dioxygenases described here incorporate the 3-His-1-
carboxylate binding motif and utilize either copper (II), nickel (II), iron (II/III). 
These enzymes all proceed by different type of substrate activation mechanisms 
allowing organic molecules to react with triplet oxygen. All structural and 
functional model complexes designed and synthesized for these enzymes avoid the 
utilization of the biomimetic imidazole ligands. The closest structural ligand 29116 
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(scheme 1.19) of the 3-His-1-carboxylate motif, though designed to mimic 
superoxide dismutase active sites,117 only incorporate two imidazole units at the C2 











The replacement of the third imidazole by an amino group, to simplify the 
synthesis, was likely not to reproduce accurately the binding environment and the 
electronic character of the metal. The scarcity of poly-imidazole ligand set stems 
from the difficulty of their syntheses and purifications, and the imidazoles are thus 
often replaced by aliphatic amines, pyridines or pyrazoles. However, such 
substitutes are structurally and electronically inaccurate and unlikely to reproduce 
the electronic character of the metal center. Structurally, only pyrazoles are good 
models as five membered hetero-aromatic rings, but are found to be stronger π and 
σ donors, as well as stronger π acceptors than histidine.118 All three nitrogen donor 
substitutes possess very different donor/acceptor properties vis a vis histidine and 
imidazole derivatives.118-120 These different electronic properties are also reflected 
in the wide range of aqueous basicities: (pKa imidazolium, 7.0; pyrazolium, 2.5; 
pyridinium 5.2; tertiary ammonium 9-11) of the nitrogen donors. Therefore b th the 
understanding of enzymatic catalysis and the design of efficient low molecular 
weight catalysts (functional models) would likely be improved by a faithful 
coordination environment.We therefore engaged in the synthesis of bio-accurate 





An Efficient Synthesis of the Tris[4(5)-imidazolyl]carbinol 












2.1 Introduction and background 
2.1.1 Introduction 
Hydrolytic and redox non-heme metalloenzymes generally utilize the 
binding properties of poly-histidinyl ligand sets to coordinate metals. In particular 
the three histidinyl nitrogen donor set is often found as part of the first coordination 
sphere in metalloenzymes active sites. Although many structural and spectroscopic 
models along with some functional models of poly-histidinyl-metalloenzymes have 
been prepared, very few incorporate the poly-imidazole ligand set. In order to 
address the lack of a good ligand set for the 3-His-1-carboxylate mo if found in 
dioxygenases and the shortcomings of substitutes for imidazoles, we engaged in the 
design and synthesis of poly-imidazole ligands; and sought to produce biomimetic 
metal complexes with facial three histidinyl donor set functionalzed by a 




2.1.2 Background and retrosynthesis 
The bi-facially coordinating ligand 30 was initially conceived as an 
extension of the tris[4(5)-imidazolyl]carbinol (4-TIC) (31, scheme 2.1) molecule 
first synthesized and reported by Breslow et al.121 This led us to consider the final 
target as the combination of two parts: a tripod and a pendent arm. The route to the 
desired ligand was divided into two stages: 1) a late stage functionalization of 4-



























The first synthetic challenge addressed was the synthesis of the tripodal unit as two 
different isomers could be envisaged (schemes 2.2 and 2.3). The first isomer 
possessing an all C2 point of attachment (2-TIC) 33 is much simpler to obtain than 























However, the all-C4 tripodal unit, though more difficult to access, was the one 
favored as it is a stronger binder and a better biomimetic model in its coordination 


















31 35  
Scheme 2.3 
 
These coordinating properties parallel the basicity of the ligands s 2-TIC, a weaker 
base than 4-TIC, is also a weaker complexing agent (table 2.1). 
 
Compound pK1 pK2 pK3 
4-TIC 6.95 5.23 3.37 
2-TIC 6.12 3.59 <1.5 
Table 2.1: pKa of 4-TIC and 2-TIC121 
 
 
This observation was rationalized by electrostatic repulsion.121 Upon protonation or 
metal binding, positive charges develop on the nitrogen atoms of all three rings in 
close proximity, but for geometric reasons the charges on 4-TIC 31 are further apart 


















33 31  
Scheme 2.4 
 
The stronger binding affinity and biologically relevance rendered the 4-TIC ligand 
more interesting and desirable.121 4-TIC itself had already been reported and 
Collman’s synthesis122 appeared to be especially well suited to our plan as the 




2.1.3 Syntheses of the 3-Imidazole subunit 
2.1.3.1 Breslow Syntheses 
The syntheses of poly-imidazole ligands are few and far between ith the 
initial work on imidazole based tripodal ligands reported by Breslow and 
coworkers.121,123 The 2-substituted tripod (scheme 2.5) was easily prepared in two 
steps by deprotonation by butyl lithium (BuLi) of the 2-position ortho-directed by 
the MOM protecting group 36, followed by addition of diethylcarbonate. The 
MOM-protected 2-TIC 37 could then be deprotected under strongly acidic 































The synthesis of tris(4-imidazolyl)carbinol (4-TIC) (scheme 2.6) was more 
complicated than the 2-TIC isomer as the regioselectivity of 4-substitution was only 
achieved by protecting the 2-position of 36 by a thiophenyl group to yield 38. The 
synthesis further employs the ortho-directing and protecting group MOM, which 
was critical in the deprotonation of the 5-position of 38. Breslow et al reported that 
lithium diisopropylamine (LDA) was a sufficient base to deprotonate the C5 
position, although reports elsewhere have advocated the replacement of LDA by 
BuLi as it appeared that LDA is an insufficiently strong base.124 The organolithium 
thus formed was then trapped with diethylcarbonate to yield the tris(5-
imidazolyl)carbonyl derivative 39. The first deprotection step of the C2 position 
was effected by an Al(Hg) amalgam in low yield and it is important to realize that 
compound 40 obtained cannot be used for coordination chemistry as the tripod is 
linked at the C-5 position. It therefore must be further N-deprotected under acidic 
conditions to produce the desired 4-TIC. Synthesis of the target 31 was achieved in 
5 steps (including the initial protection of imidazole) in 3-16% yield, but this route 
was deemed unsuitable for production of large amounts of the compound as 





































2.1.3.2 Collman Synthesis 
A different approach to 4-TIC was developed by Collman et al.122 and 
utilized N-trityl-4-iodoimidazole as a key intermediate 44, which was synthesized 
in three steps by an established procedure (scheme 2.7). Imidazole 41 was initially 
per-iodinated (42) and then selectively 2,4(5)-de-iodinated with aqueous sodium 
sulfite (43).125 The protection of 4(5)-iodo-imidazole 43 with trityl chloride (Tr-Cl), 

























The selective metal halogen exchange (scheme 2.8), only reported t  proceed with 
iodine,127-129 produced the 4-substituted Grignard reagent.130 Even with the 2-
position unprotected the organomagnesium bromide formed is kinetically trapped in 
methylene chloride and does not rearrange to more stable isomers (i.e. 2 and 5). It 























In our hands two problems were encountered with the N-trityl protected 4-TIC 
synthesis. The use of iodine and the massive trityl protecting group was not 
conducive to large scale synthesis as they constitute most of the mass and once 
removed only a small quantity of the final product was obtained. Secondly, as 
illustrated in greater detail later, the sterically demanding trityl protecting group 
dramatically changed the reactivity of the substrate, and hindered most electrophilic 






2.2 Results and Discussion 
2.2.1 Introduction 
Our approach (scheme 2.9) to 4-TIC was developed with the previous 
syntheses in mind and the goal to develop a practical and rapid route to 4-TIC. We 
envisioned obtaining the tripod from the doubly protected imidazole 46, as the 
critical choice of the N-protection by N,N-dimethylsulfamoyl guaranteed the ease of 
deprotonation of both C2 and C5 positions. Moreover, as the tripod would require 
further functionalization at the C2 position the tert-butyldimethylsilyl (TBDMS) 


















2.2.2 Synthesis of Tris[4(5)-imidazolyl]carbinol 31 and its derivatives 
2.2.2.1 Synthesis of 4-TIC 31 
Imidazole 41 (scheme 2.10) reacted readily with N,N-dimethylsulfamoyl 
chloride and triethylamine to yield in excellent yield (90%) the N-protected 
imidazole 47.131 Easily prepared on large scale the sulfonamide was a good starting 
material for the synthesis of 4-TIC. The sulfonamide 47 could then be protected at 
the 2-position by addition of one equivalent of BuLi and TBDMSCl at -78 °C.132 
The intermediate 46 thus formed was then deprotonated once more, in the same pot, 
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by addition of a second equivalent of base. Deprotonation at the 5-position was 
carried out at -78 °C and addition of diethyl carbonate results in the formation of 





























The product, a white solid, was fully characterized by nuclear magnetic resonance 
(NMR) and by mass spectrometry. The 1H NMR spectroscopy confirmed the 
substitution of the 2 and 4 positions of the imidazole nucleus 48 as the remaining 
C4-proton at δ 6.38 ppm was a singlet; the presence of a hydroxy group was 
supported by infra-red (IR) spectroscopy with a broad absorption band at 3300 cm-1. 
The doubly protected tripod was finally completely deprotected (scheme 2.11) in 
one step in 6N HCl at reflux for 90 minutes. The crude product was then purified by 
cation exchange chromatography which provided either the known neutral form 31 
in 88% yield, when ammonium hydroxide was used as an eluent, or to the tri-















48 31  
Scheme 2.11 
 
The characteristic resonance of the more deshielded C2-proton as a doublet (J= 0.9 
Hz) δ 7.64 ppm and the disappearance of the methyl group of the protecting groups 
by 1H NMR spectroscopy indicated that the desired product was obtained. This 
structure was further corroborated by 13C NMR spectroscopy and mass 
spectrometry which exhibited an [(M – OH)+] base peak. A crystal obtained by 
slow evaporation of a solution of the tri-hydrochloride salt 31 in methanol yielded 
crystals suitable for X-ray crystallography. The structure of the tri-hydrochloride 
salt was obtained (figure 2.1) and showed the expected structure involved in an 
extensive hydrogen bond network with chloride ions and methanol molecules: 
 
Figure 2.1: X-ray ORTEP diagram of 31·3HCl 
Selected bond distances (Å): O(1)-C(10)= 1.4157(11); N(1)-C(2)= 1.3259(14); 
N(1)-C(1)= 1.3811(12); N(2)-C(2)= 1.3235(14); N(2)-C(3)= 1.3717(13). Selected 
bond angles (°): C(2)-N(1)-C(1)= 108.46(8); C(2)-N(2)-C(3)= 109.32(9); C(3)-
C(1)-N(1)= 107.11(8); N(2)-C(2)-N(1)= 108.50(9); C(1)-C(3)-N(2)= 106.62(9). 
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 2.2.2.2 Synthesis of two derivatives 49 and 51 
The selective deprotection at the 2-position was initially attemp d by the 
action of TBAF which led to complex mixtures (scheme 2.12). This unexpected 
difficulty might be attributable to TBAF’s basicity in THF promting an 
elimination reaction give N-sulfonamide-imidazole 46 and the symmetrical ketone. 
This pathway, likely to be driven by steric relief, was shut down when CsF in 
aqueous acetonitrile was used and yielded 49 in 88% yield. The presence of water 


























48 49  
Scheme 2.12 
 
The two doublets of both imidazole protons (J= 1.2 Hz) at δ 8.01 ppm and δ 6.35 
ppm observed by 1H NMR spectroscopy and the resonance of the methyl group 
from the N-protecting group at δ 2.91 ppm indicated of the selective C2-
deprotection of the imidazole nucleus in 49.
This practical route to 4-TIC 31 and its selective C2-deprotection led us to 
consider the next stage of the synthetic plan as the functionalization of the ligand 
and its coordinating properties would be hampered by the presence of a hydroxy 
37 
 
group. We therefore tried to modify its reactivity by investigating several tactics to 
install protecting groups. Direct attempts (scheme 2.13) to protect th  product in 
situ were carried out with various electrophiles. These trapping experiments 
initially involved acetyl chloride and failed, resulting in the isolati n of the carbinol 
48. As the steric hindrance of two quaternary carbons only separated by one oxygen 
atom in the presumed intermediate may have been responsible for the bserved 
inertness, two other electrophiles were tested: iodomethane (MeI) and methyl 


























Attempts also carried out on the pure starting carbinol 48 by sodium hydride (NaH) 
treatment in THF at 0 °C followed by addition of AcCl, MeI or MeOTf led to 
decomposition of the starting material (scheme 2.14). The decomposition of 48 by 
NaH was observed by TLC analysis and supports the interpretation of the TBAF 















Methylation of the alcohol (scheme 2.15) was finally achieved under acidic 
conditions by methanolysis of the tri-cationic form of 31 in quantitative yield. The 
reaction is thought to occur via protonation of the tertiary alcohol by one of the 














N . 3 HCl
31 51  
Scheme 2.15 
 
The desired product, a white solid, proved to be extremely hygroscopic and 
displayed the expected resonance of the added methyl group at δ 3.35 ppm by 1H 
NMR spectroscopy and a slight upfield shift in the doublets of the aromatic 
imidazole from δ 9.12 ppm to δ 9.02 ppm. 
 
2.2.3 Synthesis of a 4-TIC iron (III) complex 52
With the tripod in our hands confirmation of its coordinating properties was 
sought as no crystal structure of a 4-TIC metal complex was known. The tripod was 
found to readily form a 2:1 complex (scheme 2.16), as a brown solid, in water with 
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iron trichloride. Suitable crystals for X-ray crystallography were obtained from a 
concentrated solution in methanol (figure 2.2). The structure of the complex was 
determined and it is the first structure of any metal complexed by 4-TIC. It 
displayed all three nitrogen donors of the ligand coordinated to the iron center in an 
octahedral arrangement, constituted by two 4-TIC ligands and its bond lengths and 
























Figure 2.2: X-ray ORTEP diagram of 52
Selected distances (Å): Fe(1)-N(1)= 1.9535(15); Fe(1)-N(3)= 1.9414(16); Fe(1)-
N(5)= 1.9662(15); N(1)-C(3)= 1.329(2); N(1)-C(1)= 1.378(2); C(1)-C(10)= 
1.516(2). Selected bond angles (°): N(3)-Fe(1)-N(1)= 92.96(6); N(3)-Fe(1)-N(5)= 





This improved and shortened route, 50-55% overall yield from imidazole, is 
a three pot procedure with limited and simple purification steps. Indeed the two 
previous syntheses are longer and technically much more difficult as the imidazole 
derivatives are purified by column chromatography on silica gel with eluents 
saturated with ammonia.122 This important improvement of the synthesis of 4-
imidazolyl carbinols helped us to push forward large quantities of the fully 
deprotected material. It also facilitated the investigation of the coordination 
chemistry of 4-TIC. Potential further modifications of the 2-positi n could now be 
reasonably envisioned as we turned our attention to discover efficient 
functionalizations of imidazoles at the 2-position with a model substrate. 
 
2.3 Functionalization of 4-TIC 
2.3.1 Introduction and background 
The functionalization of imidazoles at the 2-position can be carried out in 
various ways. The preparation of 2-(2-imidazolyl)acetophenones134 (scheme 2.17), 
for example, demonstrates the feasibility of addition of an ester group and though 






















This procedure requires the presence of two specific features: 1) a methyl group at 
the 2-position of the imidazole 53 and 2) an activating protecting group. The first 
requirement could conceivably be met by simple addition of the methyl group onto 
the N-protected 4-TIC 56 (scheme 2.18), but additional modifications of the 
protecting groups are likely to render the route to 57 or 58 very lengthy. Moreover, 
the poor solubility properties and the difficulty in purifying poly-imidazole tripods 






































The formation of organolithium species, using strong bases such as BuLi, and their 
addition to halogenoacetates was also considered. However, the reactivity of 2-
lithio-imidazoles with different t-butyl halogenoacetates was moderated by the 
neighboring protecting group, as reported in a study of additions of sulfonamide 47 































 X= Cl X= Br X= I 
47, R1= R2= H 33 (66 %) 0 35 (26 %) 
Table 2.2: Product distribution and yields from scheme 2.19135 
 
The chloro-derivative underwent attack at the ester to furnish the chloroketone 59, 
whereas the t-butyl iodoacetate transfered iodine to the imidazole in low yields, 
product 61. Substitution at the C2 position under classical conditions is rather 
capricious and the reactivity seems to be hampered by the electron withdrawing 
sulfamoyl protecting group. Moreover, when the bromo-acetate did behave in the 
desired way (scheme 2.20) (e.g. with the trityl protecting group) the product 63 

























We therefore sought milder and more selective conditions in order to effect
the required transformation. Itoh and coworkers’ work was deemed more 
reasonable and further investigated.136,137 The reactivity of the imidazole nucleus 
can be greatly modified by purposefully choosing activating groups. When 
protected by a strong electron withdrawing group and activated further by a second 
one (scheme 2.21), the 2-position of the imidazolium salt 65 becomes electrophilic 

























The imidazoline 67 can in a second step be re-aromatized to imidazoles 68 with 
















2.3.2 Results and Discussion 
We initially sought to confirm Coutts et al.135 report as a successful addition 
of t-butyl bromoacetate would have provided us with a direct entry to 
functionalized 4-TIC. However, analysis of the crude products by 1H NMR 



















We therefore turned our attention to a preliminary study of the applic bility 
of Itoh’s chemistry. The reactions were performed on a model substrate 47 in order 
to determine its reproducibility and practicality. Moreover, we were also greatly 
interested in the re-aromatization step as only one imidazole-containing substrate 
68 had been reported. This reaction was reproduced with our particular ketene silyl 
acetal138 to give us the desired imidazoline 69 in good yields (55%) as a colorless 
oil (scheme 2.24). The loss of aromatic resonances in the product was confirmed by 



















We then proceeded to test the functional group tolerance of the deprotection and 
aromatization steps as the ester was potentially reactive under the conditions of the 



























Upon treatment of 69 with potassium hydroxide followed by addition of o-chloranil 
or ferric salts a white solid was isolated in 63% yield and characte ized by 1H and 
13C NMR spectroscopy. The unusual low field resonances of an aromatic nucleus 
and the absence of the expected molecular ion by mass spectrometry excluded the 
formation of 70. The mass of the isolated compound was missing 14 au, 
corresponding to a nitrogen atom. Crystals obtained from a solution of 71 in 
methanol were analyzed by X-ray crystallography which establi hed the structure 






Figure 2.3: X-ray ORTEP diagram of 71
Selected distances (Å): C(6)-C(7)= 1.4291(14); C(7)-C(8)= 1.3704(15); C(8)-N(1)= 
1.3743(15). Selected angles (°): C(9)-C(6)-C(7)= 107.19; C(9)-C(6)-C(5)= 
124.01(9); C(7)-C(6)-C(5)= 128.64; C(8)-C(7)-C(6)= 106.77(9) 
 
Formation of pyrrole 71 can be rationalized by the presence of an acidic 
methylene group alpha to the carboxyl group and by the good nucleofgacity of the 
sulfonamide, both of which could promote an initial elimination-ring opening step. 
This would then be followed by loss of the sulfonamide group and finally ring 
closure. This Tiffeneau-Demjanov rearrangement139,140 further highlights the 
potential problem posed by acidic C-Hs flanked by the ester and imidazole nucleus. 
 
2.4 Conclusion 
To summarize we developed a practical and efficient route to the 4-TIC 
ligand in a three pot procedure in excellent yield (50-55%) over three steps.141 
We also explored further functionalization of 4-TIC but no satisfactory 
method was found and we thus re-evaluated our approach. The more conservative 
option was to push the current line of investigation by slight modifications of the 
deprotection step. Using acidic conditions to deprotect the carbamate and 
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sulfonamide might be a more selective. However, a second and more radical 
approach was finally chosen. The original the organic target was modified since the 
methylene group appeared to be responsible for most side reactions observed. It 
was replaced by a geminal dimethyl group which would most likely preempt other 
potential side reactions during the synthesis of a 3-Imidazole-1-carboxylate ligand. 
















Materials and Methods: 
All operations were carried out under argon by means of standard Schlenk 
and vacuum-line techniques. Organic solvents were dried by standard procedu es 
and distilled under Ar before use. CH2Cl2 was dried over CaH2 and distilled under 
Ar before use; THF was dried over Na using benzophenone as indicator and 
distilled under Ar before use; methanol was dried over Mg and I2 and distilled under 
argon. Glassware was oven-dried at 110 °C overnight. IR spectra were recorded in 
KBr pellets with a Perkin-Elmer 283-B infrared spectrophotometer (resolution 4 
cm-1). The 1H (300 MHz), and 13C (75.5 MHz) NMR spectra were recorded on a 
Varian Mercury-300 spectrometer. Mass spectra were acquired on a Fin igan TSQ 
700 spectrometer (ESI) in methanol solution. Compound 47131 was prepared by a 
known procedure and matched the spectroscopic data available. 
 
Tris(1-N,N-dimethylsulfamoyl-2-t-butyldimethylsilyl-5-imidazolyl)carbinol 48: 
1-(N,N-Dimethylsulfamoyl)-imidazole (1.85 g, 10.6 mmol) 47 was 
dissolved in dry THF (90 mL) under a positive pressure of Ar. With v gorous 
stirring, the temperature was lowered to -78 °C and a solution of n-BuLi in pentane 
(11.1 mmol, 5.9 mL of a 1.88 M solution, 1.05 eq.) was added drop-wise. After 
stirring for 30 min, a solution of t-butyldimethylsilyl chloride (12.7 mmol, 1.91 g, 
1.2 eq.) in dry THF (2 mL) was added via cannula. The reaction mixture was then 
left at room temperature overnight. The solution was cooled to -78 °C and a 
solution of n-BuLi (11.7 mmol, 6.2 mL of a 1.88 M solution, 1.1 eq) was added 
drop-wise. After stirring for 30 min, neat diethyl carbonate (3.0 mmol, 425 µL, 0.33 
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eq.) was added drop-wise. The reaction was left in the dry ice-acetone bath, slowly 
warming to room temperature. After stirring 24 h, ethyl acetate (50 mL) was added 
to the reaction, and the solution was washed with brine (3  20 mL). The organic 
phase was dried with MgSO4, and the solvent removed under reduced pressure. 
During solvent removal a white solid precipitated, which was filtered off and 
washed with ethyl acetate. The filtrate was concentrated and the procedure was 
repeated to afford of the desired product as a white solid (2.19 g, 70%). No further 
purification was necessary. Melting point: decomposes above 185 °C; IR (KBr) 
3477, 2933, 2995, 2964, 1462, 1372, 1157, 959 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 6.38 (s, 3H), 5.80 (s, 1H), 2.59 (s, 18H), 1.02 (s, 27H), 0.38 (s, 9H), 0.36 (s, 9H); 
13C (75.5 MHz, CDCl3) δ 160.4, 135.2, 134.5, 71.3, 38.4, 27.6, 19.0, -2.9, -3.0; 










48 (2.04 g, 2.3 mmol) and 2.0 g (13.2 mmol, 5.8 eq.) of CsF and H2O (10 mL) were 
added to CH3CN (90 mL). The stirred suspension was refluxed for 24 h. The 
organic phase was separated and dried over MgSO4. Upon concentration of the 
organic phase a solid precipitated which was filtered off and dried; affording the 
desired product as a white solid (1.11 g, 88% yield). No further purification was 
necessary. Melting point: decomposes above 130 °C; IR (KBr) 3489, 3138, 2949, 
1555,1467, 1393, 1165, 1092, 1046, 984, 845, 729, 587; 1H NMR (300 MHz, 
CDCl3) δ 8.01 (d, 3H, J= 1.2 Hz), 6.35 (d, 3H, J= 1.2 Hz), 5.58 (s, 1H), 2.91 (s, 
18H); 13C (75.5 MHz, CDCl3) δ 141.5, 133.4, 132.7, 68.6, 38.5; HRMS (ESI +): 
exact mass calculated for C16H26N9O7S3 [M + H]






Tris(4(5)-imidazolyl)carbinol hydrochloric salt 31·3 HCl: 
Tris(1-N,N-dimethylsulfamoyl-2-t-butyldimethylsilyl-5-imidazolyl)carbinol 
48 (1.60 g, 1.79 mmol) was refluxed in hydrochloric acid (50 mL, 1.5 M) for 90 
min. The solvent was evaporated under reduce pressure. Column chromatography 
on a Dowex 50WX8-100 resin (20 mL) with water followed by 6 M hydrochloric 
acid yielded the tri-hydrochloride salt as a white solid (487 mg, 80% yield). When 
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6% NH4OH was used instead of hydrochloric acid the neutral tripod 31 was 
obtained (362 mg, 88% yield). Suitable crystals for X-ray crystallography were 
obtained by slow evaporation of a solution of 31·3 HCl in methanol. 
 
Tris(4(5)-imidazolyl)carbinol 31: decomposes at 130 °C; IR (KBr) 3386, 
3142, 2844, 2605, 1455, 1111,1088, 945, 826, 618 cm-1; 1H NMR (300 MHz, 
CD3OD) δ 7.64 (d, J= 1.2 Hz, 3H), 6.84 (d, J= 1.2 Hz, 3H; 
13C (75.5 MHz, 
CD3OD) δ 142.6, 136.5, 119.9, 70.5; HRMS (ESI +): exact mass calculated for 
C10H10N6NaO [M + Na]















Tris(4(5)-imidazolyl)carbinol hydrochloride salt (31·3 HCl) a white solid 
decomposes above 175 °C; IR (KBr) 3165, 3111, 2980, 2830, 2594, 1625, 1467, 
1420, 1100, 1065, 818 cm-1; 1H NMR (300 MHz, CD3OD) δ 9.12 (s, 3H), 7.75 (s, 
3H); 13C (75.5 MHz, CD3OD) δ 137.8, 135.1, 120.2, 66.6; HRMS (ESI +): exact 
mass calculated for C10H10N6NaO [M + Na]











Table 2.3: Crystal data and structure refinement for 31·3 HCl 
Empirical formula C10 H13 Cl3 N6 O 
Formula weight 339.61 
Temperature 120(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions 
a= 7.5651(5) Å, α= 90°. 
b= 22.9874(15) Å, β= 94.2420(10)°. 
c= 8.3708(5) Å, γ= 90°. 
Volume 1451.71(16) Å3 
Z 4 
Density (calculated) 1.554 Mg/m3 
Absorption coefficient 0.636 mm-1 
F(000) 696 
Crystal size 0.22 x 0.08 x 0.02 mm3 
Theta range for data collection 1.77 to 27.49°. 
Index ranges -9<=h<=9, -29<=k<=28, -10<=l<=10 
Reflections collected 17459 
Independent reflections 3318 [R(int)= 0.0171] 
Completeness to theta= 27.49° 99.8 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9874 and 0.8728 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3318 / 0 / 182 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I)] R1= 0.0279, wR2= 0.0705 
R indices (all data) R1= 0.0297, wR2= 0.0719 






Tris(4(5)-imidazolyl)methoxymethane hydrochloric salt·methanol 51: 
Tris(4(5)-imidazolyl)carbinol hydrochloride 31·3 HCl (201 mg, 0.59 mmol) 
dissolved in dry MeOH (20 mL) was refluxed for 19 h under positive pressure of 
N2. A soxhlet apparatus was used whose thimble was filled with activated 4Ǻ 
molecular sieves. The solution was concentrated under reduced pressure and 
acetone was added to precipitate the desired product, which was filtered off and 
dried. The product co-crystallized with one molecule of methanol (determined by 
NMR) in quantitative yield. The methanol-free product (hygroscopic) could be 
obtained as a white solid by extensive washing with acetone prior drying. IR (KBr) 
3103, 2995, 2833, 2609, 1602, 1474, 1104, 841, 618 cm-1; 1H NMR (300 MHz, 
CD3OD) δ 9.02 (d, J= 1.2 Hz, 3H), 7.83 (d, J= 1.2 Hz, 3H), 3.35 (s, 3H); 
13C (75.5 








Bis(tris(4(5)-imidazolyl)carbinol)iron(III) chloride 52: 
FeCl3 (46 mg, 0.29 mmol, 1 eq.) and tris(4(5)-imidazolyl)carbinol 31 (132 
mg, 0.58 mmol, 2 eq.) were dissolved in H2O (10 mL) and stirred for 3 h. The 
solvent was removed under reduced pressure and the crude material dissolved in 
MeOH. Upon slow evaporation dark brown crystals formed and were filtered off, 












Table 2.4: Crystal data and structure refinement for 52 
Empirical formula C24 H40 Cl3 Fe N12 O8 
Formula weight 786.88 
Temperature 99(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions 
a= 10.7760(8) Å, α= 83.5450(10)°. 
b= 10.9987(8) Å, β= 80.8150(10)°. 
c= 16.6397(13) Å, γ= 63.8040(10)°. 
Volume 1745.0(2) Å3 
Z 2 
Density (calculated) 1.498 Mg/m3 
Absorption coefficient 0.724 mm-1 
F(000) 818 
Crystal size 0.38 x 0.26 x 0.24 mm3 
Theta range for data collection 2.07 to 27.50°. 
Index ranges -13<=h<=13, -14<=k<=14, -21<=l<=21 
Reflections collected 21063 
Independent reflections 7841 [R(int)= 0.0143] 
Completeness to theta= 27.49° 99.0 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8453 and 0.7704 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7841 / 6 / 437 
Goodness-of-fit on F2 1.016 
Final R indices [I>2sigma(I)] R1= 0.0421, wR2= 0.1156 
R indices (all data) R1= 0.0434, wR2= 0.1166 







acid ethyl ester 69 
To a stirred solution of 47 (1.02 g, 5.8 mmol, 1 eq.) in freshly distilled 
acetonitrile (30 mL) the ketene silyl acetal138 (2.98 g, 11.6 mmol, 2 eq.) was added. 
The reaction mixture was then cooled to 0 °C and methyl chloroformate (0.38 mL, 
4.8 mmol, 1.2 eq.) added dropwise. The reaction mixture was left to warm to room 
temperature for 2 h. The solvents were removed in vacuo and the crude was 
purified by flash column chromotagraphy on silica gel (6 hexanes: 4 AcOEt) to 
yield 69 as a colorless oil (1.17 g, 56% yield). The product was characterized by 1H 
(300 MHz, CDCl3) δ 6.00 (broad multiplet, 3H), 3.77 (s, 3H), 2.91 (s, 6H), 2.90 (s, 
2H), 1.43 (s, 9H); MS (ESI+) exact mass calculate for C12 H21 N2 O6 S [M + H]
+ 








1H-Pyrrole-3-carboxylic acid tert-butyl ester 71
To a stirred solution of imidazoline 69 (1.17 g, 3.22 mmol) in acetonitrile(70 
mL), a 1N NaOH (9 mL) solution was added and then refluxed for 4 h. To the room 
temperature reaction mixture AcOEt (50 mL) were added and the organic phase 
was then washed with brine (2  20 mL) and dried over anhydrous MgSO4. The 
solvent was removed under vacuum and the solid resulting was purified by flash 
column chromatography (7 hexanes: 3AcOEt) to yield 71 as a white solid (339 mg, 
63% yield). IR (KBr) 3344, 2980, 1674, 1550? 1477, 1420, 1369, 1350, 1246, 
1136; 1H NMR (300 MHz, CDCl3) δ 7.34 (m, 1H), 6.73 (m, 1H), 6.59 (m, 1H), 
1/551 (s, 9H); 13C NMR (75.5 MHz, CDCl3) δ 164.8, 123.2, 118.6, 118.2, 79.7, 
28.4; MS (ESI +): exact mass calculated for C9H13NO2Na [M + Na]

























Table 2.5: Crystal data and structure refinement for 71 
Empirical formula C9 H13 N O2 
Formula weight 167.20 
Temperature 110(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P2(1) 
Unit cell dimensions 
a= 5.9895(5) Å, α= 90°. 
b= 8.2125(7) Å, β= 91.5430(10)°. 
c= 9.3453(7) Å, γ= 90°. 
Volume 1745.0(2) Å3 
Z 2 
Density (calculated) 1.208 Mg/m3 
Absorption coefficient 0.085 mm-1 
F(000) 180 
Crystal size 0.32 x 0.24 x 0.14 mm3 
Theta range for data collection 2.18 to 28.30°. 
Index ranges -7<=h<=7, -10<=k<=10, -12<=l<=11 
Reflections collected 5249 
Independent reflections 2125 [R(int)= 0.0187] 
Completeness to theta= 27.49° 96.7 % 
Absorption correction None 
Max. and min. transmission 0.9881 and 0.9732 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2125 / 1 / 112 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1= 0.0298, wR2= 0.0762 
R indices (all data) R1= 0.0299, wR2= 0.0763 
Absolute structure parameter 0.8(7) 






Deprotection attempt of 48 using TBAF (scheme 2.12): 
To a solution of tris(1-N,N-dimethylsulfamoyl-2-t-butyldimethylsilyl-5-
imidazolyl)carbinol 48 (0.200 g, 0.224 mmol) in THF (10 mL), a 1 M solution of 
TBAF (3 mL) was added dropwise. The solution turned yellow and was stirred for 
2 h at room temperature. The organic phase was separated and dried over MgSO4. 
TLC (95 EtOAc: 5 MeOH) and 1H NMR spectroscopy analysis of the crude 
mixture revealed a complex mixture which could not be purified. 
In situ protection of 48 (scheme 2.13): 
See prior procedure to synthesize 48. The procedure was only modified in 
its quenching procedure whereby EtOAc and H2O were replaced by the desired 
electrophile and stirred at room temperature for 1 h. Aqueous work-up gave 48 in 
yields not significantly different from the normal procedure. 
Addition of bromo-acetic acid tert-butyl ester to 47 (scheme 2.23): 
1-(N,N-Dimethylsulfamoyl)-imidazole (0.500 g, 2.85 mmol) 47 was 
dissolved in dry THF (30 mL) under a positive pressure of Ar. With v gorous 
stirring, the temperature was lowered to -78 °C and a solution of n-BuLi in pentane 
(3.14 mmol, 1.7 mL of a 1.88 M solution, 1.1 eq.) was added drop-wise. After 
stirring for 30 min, bromo-acetic acid tert-butyl ester (3.14 mmol, 0.47 mL) was 
added neat. The reaction mixture was then left at room temperature ove night and 
quenched with H2O. The organic phase was separated and the organic solvent 
removed under reduced pressure to yield the starting material by 1H NMR analysis 






Synthesis of the Mixed Carboxylate-Functionalized Carbinol 73 










3.1 Introduction: retrosythetic analysis 
The initial route devised to reach the desired target 73 appeared problematic 
due to unforeseen difficulties encountered in purifying these poly-imidazole 
containing molecules, compounded by unfavorable physical properties such as poor 
solubility. All but methanol and water were found to solubilize 4-TIC and thus with 
such a limited arsenal of solvents most transformations considered became almost 
intractable. In order to secure enough material and study the coordination chemistry 
of the 3-Imidazole-1-carboxylate ligand, it became clear that tese properties 
always be kept in mind when designing a synthetic plan in order to maximize yields 
and ease of isolation. The direct illustration of this strategy is the incorporation the 
pendant arm in one of the initial building blocks rather than the initial late 
functionalization strategy (scheme 3.1 and 3.2). Indeed, the fewer the number of 
steps involving the tripod itself the greater the chances of succe s, and therefore the 
target was envisioned via two different routes. The first one investigated (scheme 
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3.1) was the addition of a functionalized imidazole moiety 76 already bearing the 











































The second approach (scheme 3.2), a complementary route, envisioned the addition 

















Both of these routes are aiming at a 4-TIC analogue as the ultimate target. 
The synthesis of a model substrate 73, a mixed tripod with a C4 and two C2 
linkages, was initially considered by the simplified path delineated in scheme 3.3. 
This approach was a model study to the more complex target and, as shown in the 
retrosynthetic scheme below, one of the obvious advantages of such a strategy is 
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3.2 Synthesis of precursors 80 and 81 
3.2.1 Synthesis of protected imidazole 85 
Reports of 2-functionalized imidazoles with the desired oxidation state on 
the side-chain were not available at the time of the synthetic work, but the known 2-
(1H-imidazol-2-yl)-2-methyl-propan-1-ol 83 (scheme 3.4) seemed to display all the 
required features for an initial test of the proposed synthetic route. The compound is 
readily available in gram quantity in two steps (37% yield overall) and makes for a 
good starting point. Condensation of formaldehyde and iso-butyraldehyde led to the 
hydroxy aldehyde 82 which once condensed with glyoxal and ammonium 





















The alcohol 83 was then protected with TBDMS-Cl in methylene chloride in the 
presence of imidazole, as a base, in excellent yield (94% yield) (scheme 3.5). The 
white product was easily purified by recrystalization from acetonitrile and 
characterized by NMR spectroscopy. The 1H NMR signals of the TBDMS group 
and their relative integration supported the assignment of the product. The identity 
of 84 was also confirmed by 13C spectroscopy and mass spectrometry. N-protection 
performed at room temperature with NaH and N,N-dimethylsulfamoyl chloride 
yielded the desired compound 85 in good yield (72%). The characterization of 85 
was simplified by the appearance of two doublets, δ 7.19 ppm and δ 6.95 ppm with 
a coupling constant of J= 1.5 Hz from the imidazole ring protons and the 
resonances of the sulfamoyl protecting group. Further characterization by 13C NMR 














84 85  
Scheme 3.5 
 
The pro-nucleophile was thus rapidly prepared in four steps in an overall yi ld of 
25% from iso-butyraldehyde. Lithiation at the C5-position was probed by addition 
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of BuLi at -78 °C and quenching with deuterated methanol. Complete deu ration 
of the 5-position was observed by 1H NMR spectroscopy (scheme 3.6). The 
characteristic doublets of the aromatic ring in 85 became a singlet in 85-d, 
confirming the quantitative lithiation at the desired position. With these results 











85 85-d  
Scheme 3.6 
 
3.2.2 Synthesis of symmetrical bis-imidazolyl ketones 87-89 
Symmetrical 2-imidazolyl-ketones are known and some preparations have 
been published. We settled for C-2 ketones as model substrates due to th ir 
availability and the N-methyl protected ketone 87 was easily prepared in large 










86 87  
Scheme 3.7 
 
One of the problems encountered with ketone 87 was its low solubility in aprotic 
solvents such as THF, which rendered its handling in reactions where BuLi was 
used rather difficult. In order to address this obstacle other ketones were also 
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prepared. The known ketones capped by a benzyl (Bn) 88144 or a para-
methoxybenzyl (PMB) 89 protecting group145 showed increased solubility in 
organic solvents. The preparations of these two ketones were carrid out according 
to the published procedures via the formation of a Weinreb amide and were utilized 
as electrophilic partners in the addition reaction (scheme 3.8). Ketones 88 and 89 
were obtained in 81% yield and 92% yield respectively, as white solids and were 























3.2.3 Addition attempts of 85 to 87-89 
All three synthesized ketones 87-89 were used in addition attempts (scheme 
3.9). Initially, the 1-methyl-imidazolyl ketone was added to the reaction mixture via 
cannula where the nucleophilic partner was preformed at -78 °C with one 
equivalent of BuLi. 1H NMR analysis of the crude mixture confirmed a lack of the 
expected product and the formation of a myriad of imidazole-containing products. 
Although the failure to obtain the expected product was initially blamed on the poor 
solubility of the reactant 87, reactions carried out with electronically equivalent 































These surprising results presented us with a rather difficult problem since no 
obvious reasons for these failed attempts could be put forward. The initial
simplification of the synthetic route using a 2-imidazolyl-ketone seemed unlikely to 
be responsible for this lack selectivity. Despite the negative results we turned our 
attention to the preferred substrate 90= (75 with P1= SO2NMe2 and P
3= TBDMS) 
(scheme 3.10) hoping that our success in forming 48 in the synthesis of 4-TIC 
(scheme 2.10) would translate to this slightly modified version. A direct parallel 
could be drawn between routes A and B as an intermediary ketone was presumably 


































3.3 Modification and optimization of precursor syntheses 
3.3.1 Introduction: oxidation attempts of alcohol 83 
Oxidation of the alcohol (scheme 3.11) to the carboxylic acid was also 
probed on the model compound146-148. This oxidation proved to be more complex 
than anticipated initially since purification of the zwitterionic product was 
complicated by its water solubility. Only the oxidizing system involving 2,2,6,6-
tetramethylpiperidine 1-oxyl (TEMPO) and iodobenzene diacetate (BAIB) seemed 
to produce any crude products that included the desired target, as determin d by in 
situ 1H NMR spectroscopy. No optimization or isolation of the product was 













Table 3.1: Reactions of scheme 3.11 
 
3.3.2 Modifications and synthesis of precursor 54 
The nucleophilic imidazole component 85 even though practical for its ease 
of preparation, presented the major drawback of having its side chain in the wrong 
Entry catalyst Stoichiometric oxidant Additives 
1 RuCl3·3H2O TCCA TBAB, Na2CO3 
2 TEMPO BAIB n/a 
3 TEMPO TCCA n/a 
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oxidation state. This side chain was initially incorporated to prevent too many late 
stage chemical transformations but was not the best possible option. A more 
effective strategy would be to carry through the entire synthesis the desired tether in 
its correct oxidation state as an ester (scheme 3.12). Adding such an electrophilic 
site in the precursor was apparently trading one problem for another as the 
compound must be deprotonated by the nucleophilic base BuLi. We therefore 
envisioned the use of an ortho-directing group (ODG) on the imidazole nucl us, 
which along with the sterically encumbered vicinal gem-dimethyl unit, would 









The desired new compound 94 was expeditiously synthesized by the 
oxidation of hydroxymethyl pivalate149 91 to 92 and without purification, engaged 
in the condensation to the imidazole derivative 93 (scheme 3.13) in 63% overall 
yield. The compound was easily purified by precipitation from EtOAc and fully 
characterized by NMR spectroscopy with three resonances at δ 6.99 ppm (s, 2H), δ
3.72 ppm (s, 3H) and δ 1.66 ppm by 1H NMR and a more informative 13C NMR 
spectrum. The structure assignment was also supported by IR spectro copy 
(υ(CO)= 1729 cm-1) and mass spectrometry (ESI +: exact mass calculated for 
C8H13N2O2 [M + H]
+ 169.0972. Found 169.0962). Protection of the imidazole was 
carried out with N,N-dimethylsulfamoyl chloride and NaH to furnish the required 
precursor 94 in 60% yield. This white solid was again characterized by 1H NMR 
73 
 
spectroscopy and the diagnostic appearance of two doublets of an N-substituted 
imidazole at δ 7.11 ppm and δ 7.01 ppm with coupling constant J= 1.5 Hz. The 13C 
























The regioselectivity of the lithiation of the compound and its stability to 
nucleophiles was tested in a deuteration experiment (scheme 3.14). Complete 
incorporation of deuterium at C5, indicated by the disappearance of the aromatic 
doublets and appearance of a single aromatic singlet, allowed us to confirm the 
quantitative lithiation of 94 within the detection limit of 1H NMR spectroscopy. No 
apparent decomposition of the methyl ester was detected by 1H NMR analysis of 




















3.4 Synthesis of bis-imidazolyl ketone 90 
3.4.1 First approach 
Since our true goal was to obtain a 4-TIC derivative, the symmetrical ketone 
90 of routes A and B (scheme 3.10) was a desired intermediate and could 
potentially be beneficial to the addition reaction by involving the pr sumed 
intermediate in the condensation of tripod 48. The synthesis of the ketone 90 was 
more challenging than expected as the known procedures to form the desir d 
product were quite ineffective. The simple transposition of the procedure, used to 
synthesize N-alkyl and N-benzyl symmetrical ketones 87-89, to imidazole 47 
(scheme 3.15), yielded only the undesired amide 95 and the starting material 47 as 
determined by 1H NMR analysis. Attempts to modify the procedure by adding 
TMEDA or using Weinreb’s amide did not improve the reactivity. This reactivity 
was observed either at the C2 (47) or the C5 (46) position and further confirmed 






















3.4.2 Second approach 
The inability to form the desired ketone 90 was circumvented by a two step 
procedure (scheme 3.16). First sulfonamide 47 was added to 0.5 equivalent of ethyl 
formate, using a “one pot procedure”, to yield the secondary symmetrically 
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substituted alcohol 96, in 51% yield. The compound was characterized by 1H NMR 
spectroscopy and featured a doublet from the methine proton at δ 5.53 ppm and a 
doublet from the hydroxy proton at δ 3.58 ppm with J= 3.6 Hz. The composition of 
96 was further supported by mass spectrometry (ESI+) through a diagnostic peak at 
















47 96  
Scheme 3.16 
 
The conditions for oxidation of the secondary alcohol were surveyed using different 
known methodologies. General conditions reported with PCC, DDQ, 
tempo/TCCA152, I2/tempo
149, MnO2
153, IBX154,155 all failed to produce ketone 90 
from the alcohol and led to decomposition products. A milder oxidant was sought 
in the Dess-Martin periodinane reagent which proved indeed to be more effective. 
NMR analysis of the reaction mixture clearly indicated the clean formation of the 
product but also its decomposition when the conversion of the reactants re ched an 
acceptable level. The release of protons during the oxidation was identified as a 
potential catalyst for a decomposition pathway, but no improvements were
observed when an inorganic solid base such as sodium bicarbonate (NaHCO3) was 
added. However the decomposition stopped almost completely when imidazole was 
added to the reaction mixture (scheme 3.17) and 90 was isolated in 60% yield and 
characterized by 1H and 13C NMR. The diagnostic deshielded aromatic protons 
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were observed at δ 7.55 ppm supporting the oxidation of the secondary alcohol to 






















Similarly to H2O and 
tBuOH156, imidazole was thought to act as a ligand rather than 
a base; replacing imidazole by tBuOH led to comparable results. 
 
3.4.3 Addition attempts with the new precursors 90 and 94 
With the two exact desired precursors 90 and 94 in our hands, attempts to 
conclude the synthesis by performing the required condensation were carried out 
(scheme 3.18). It was regrettably found that the reaction did not yield th  expected 
product and the two starting materials were completely recovered with no 
decomposition. According to the 1H NMR spectrum of the crude reaction mixture 
only the reactants were detectable with no formation of other compounds; hence it 

































The formation of the 5-lithio-imidazolyl starting material from 94 (scheme 3.18) 
was confirmed multiple times by deuteration and no reason has been found for the 
lack of reactivity of the reactants. It is all the more remarkable that a clear parallel 
can be drawn between route A (scheme 3.10), assumed to occur during the 
preparation of 48, and B, this reaction. One can speculate on the electronic 
differences of the two pathways which could result in a potential energy mismatch 
of the reactants. The opposite inductive effects of the silyl group on 46 and 
carboxyl group on 94, at the 2-position, could explain the difference in behavior. 
Indeed, TBDMS, an electron releasing group used in the synthesis of 48, is directly 
attached to the aromatic ring, whereas the carboxyl group, inductively withdrawing, 
could deactivate the nucleophile 94 rendering it inefficient. As more unexpected 
results from such addition reactions were observed, attempts to model an  
understand the reactivity of the imidazole containing molecules by computational 
analysis is provided later. 
 
3.5 Second and third approach of a build-in carboxylate tether 
3.5.1 Introduction: retrosynthetic analysis 
As the first approach of the appended tripod failed to produce a viable route, 
a second look at the retrosynthetic analysis led us to investigate he synthesis of the 
target 73 (scheme 3.19.1) as the direct regioselective addition product of two 
equivalents of sulfonamide 47 to 98 (scheme 3.19.2). The necessary compound 
should easily be prepared as most of the chemistry required for a pr per probe has 




































3.5.2 Synthesis of precursor 98
3.5.2.1 Synthesis of diester 98
This new electrophile was simply obtained by deprotonation at the C5-
position of 94 and quenching with methyl chloroformate (scheme 3.20). The 
product was easily purified and modification of the aromatic resonances (two 
doublets) in the 1H NMR spectrum to a more deshielded singlet at δ 7.61 ppm 
confirmed the addition of the carboxyl group on the imidazole ring. The compound 
was fully characterized by 13C NMR spectroscopy and its composition verified by 

















3.5.2.2 Addition attempts 
Two reactions were attempted on the diester 98 (scheme 3.21). First, the 
addition reaction of the 2-lithio-N-sulfonamide imidazole, obtained from 47, 
showed by 1H NMR and TLC analysis the presence of numerous products in the 
crude reaction mixture. After aqueous work-up, reactant 47 was clearly detectable 
but 98 did not seem to have survived the reaction. This conclusion was further 
corroborated by the reaction of the 5-lithio-2-TBDMS-imidazole, obtained from 46, 
with 98 with similar results. After aqueous work-up, no apparent consumption of 46 













47: R = H




























These observations were difficult to explain and a hypothesis was 
formulated. The sulfamoyl protecting group used could be responsible for such a 
contrarian behavior of the reactions. This was circumstantially supported by the 
radical modification of the nucleophilicity of imidazoles, as the organo-lithium 
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species could not be added to amides (scheme 3.15) as observed by Katritzsky 150, 
Brown 151 and us. In the present case the strong electron withdrawing ability of the 
sulfamoyl protecting group could facilitate electron transfer from the organo-
lithiums 46-47 to 98 to form a stable radical anion (equation 3.1). 
    	  ·   · 
Equation 3.1 
 
In order to test this hypothesis, we decided to modify the electroni  character of the 
imidazole diester 98 by introducing a more electron rich protecting group. 
 
 
3.5.3 Third approach of a build-in carboxylate tether 
3.5.3.1 Synthesis of MOM-protected imidazole 100 
Introduction of a MOM protecting group on 98, chosen for the ease of its 
removal under acidic conditions, was simply accomplished in two steps by a
deprotection/protection sequence (scheme 3.22). The sulfonamide protecting group 
was promptly removed in methanol with catalytic amount of sulfuric ac d to yield 
99 in 85% yield, which displays a very broad singlet for the aromatic proton. The 
signal was sharpened by protonating 99 with deuterated trifluoroactic acid. The 
compound 99 fully characterized spectroscopically and then regioselectively 
protected using one equivalent of NaH and chloromethyl methyl ether (MOM-Cl) 




























The C4 location of the ester was established by a NOESY experiment. Irradiation 
of the methylene group of the MOM protecting group allowed us to detect the 
methyl group of the MOM and gem-dimethyl unit by NOE but more importantly 
the resonance of the aromatic proton was also enhanced (Figure 3.1: NOESY 
experiment on 100). 
 
 
Figure 3.1: NOESY experiment on 100 
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3.5.3.2 Addition attempts to 100 and synthesis of 73 
With compound 100 readily available we then tested the addition reactions 




















































All the pro-nucleophiles 36, 46, and 101-103 were recovered after aqueous work up 
of the reaction mixture, but as previously described the electrophile 100 was 
completely consumed and could not be recovered (scheme 3.23). Only one 
substrate 47 was found to be effective for the double addition to 100 (scheme 3.25). 
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Though completely specific to a single reactant, one should emphasize that this 
reaction proceeded smoothly to the desired compound 97 in 74% yield. The 
expected two doublets of the nucleophilic imidazole protons at δ 7.31 ppm and δ 
6.93 ppm with a coupling constant J= 1.5 Hz were detected by 1H NMR 
spectroscopy along with the singlet of the electrophilic imidazole proton shifted 




























The synthesis could thus be completed by hydrolysis of the protecting groups, 
sulfamoyl and MOM, and the ester in 6N HCl to give after purification by cation 


























As determined by 1H NMR, the compound displayed the expected three resonances 
at δ 7.17 ppm (4H), δ 6.81 ppm (1H) and δ 1.55 ppm (6H). The white solid was 
found to be soluble only in methanol and water most likely due to the presence of 
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its zwiterionic form. Full characterization by 13C NMR, IR spectroscopy and mass 
spectrometry confirmed the structure of 73.
 
3.6 Computational Studies 
3.6.1 The influence of the protecting groups in terms of electron 
affinity 
 
The successful addition of 47 and only 47 to the diester 100 was 
investigated in greater depth as to better understand what the required 
characteristics of an effective nucleophile were. We were especially interested in 
understanding why compounds 36, 46, and 101-103 were not competent 
nucleophiles. Computational chemistry was used to examine the frontier rb tals to 
try to elucidate the reasons for such a narrow scope and to develop a predictive 
model to identify which reaction partners would combine effectively.  
 
The LUMOs of 98 and 100 were calculated using the density functional 
method (DFT) at the B3LYP 6-311+G(d,p)//6-31+G(d) level and are displayed 
below (figure 3.2). As expected, the strong electron withdrawing capacity of the 
sulfonamide 98 shows a more extensive delocalization of the LUMO (orbital 
accepting an electron) on the aromatic ring (on the C2 carbon) tha the MOM 





98     100 
Figure 3.2: LUMOs of 98 and 100, isocontour at 0.08 au 
 
The vertical electron affinities were calculated at the same level of theory 
from equations 3.1 (∆Hreaction= -EA)
157 and interestingly showed a slightly 
exothermic process for the sulfonamide 98 whereas it is endothermic for the MOM 
protected imidazole 100 (table 3.2). 
 
98 + 1e- → 98-·    and   100 + 1e- → 100-· 
Equations 3.1 
 
 98 100 
∆H= (-)vertical EA (eV) -0.03 0.49 
Table 3.2: (-)Vertical EA (eV) 
 
The opposite signs for the enthalpy of reaction reinforced the notion that the 
protecting group was at least partially responsible for the observed reactivity. As 
organolithiums can be considered good reducing agents, the ease with which the 
electrophilic partner accepts a single electron might be responsible for promoting 
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side reactions and their decomposition. This explanation was obviously not 
complete and one needed to address the limited number of competent nucleophiles 
discovered for this transformation. 
 
3.6.2 Ionization of the nucleophiles 36, 46, 47, 101-103 
If the model is consistent one should observe that stronger reducing 
reactants are ill suited nucleophiles for the addition to the MOM-protected 
imidazole. This trend was verified by calculating the energy of the HOMO of each 
nucleophile engaged in the reaction, using the DFT method with the B3LYP 6-



































Energy in eV (HOMO) -5.57 -5.46 -5.83 
Table 3.3: HOMO energies of selected nucleophiles 
 
Satisfyingly, the only imidazole capable of addition of 47 is also the weakest 
reducing agent (lower energy of HOMO), as Koopman theorem states hat the 
average orbital (HOMO) energy is equal to the ionization potential. However, these 
calculations are not complete as many assumptions were made and used to simplify 
the model. The first and probably the most important is the physical tate of the 
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nucleophiles themselves as the aggregation state of the substrate was assumed to be 
monomeric, which may not be accurate. Moreover calculations of enthalpies of 
reactions are notorious for their basis set dependence and a more accurate 
determination is usually achieved by a G2 or G3 calculation which was not 
available to us at the time. And last but not least the calculations are done in the gas 
phase not representative of the true reaction conditions in solution. 
To conclude the reaction is partially explained in terms of ionization potential 
and electron affinity. We can therefore speculate that a competent nucleophile must 
have its HOMO energy at least equal to or lower than that of the 2-lithio-N-
sulfonamide imidazole obtained from 47 (≈ -6 eV). If correct in our interpretation, 
the energy of the HOMO of the nucleophile can be used as a condition necessary, 
but not sufficient for a successful addition. 
 
3.6.3 Conclusion 
We developed an effective synthesis of a mixed tripod C2 and C4 with a 
carboxylate tether in 8 steps (longest linear sequence) with an overall yi ld of 
~15% from hydroxy pivalate methyl ester, a cheap commercially vailable 
compound. Moreover we also provide a rational for the limited substrate scope 
observed in the addition reaction to 100. Our calculations should provide guidelines 
in the choice of protecting groups and nucleophiles. The sulfamoyl protecting group 
should not be used in the presence of strong reducing agent and the HOMO of the 





3.7 Coordination chemistry and metal ion complexation by 73 
3.7.1 Addition of base and its effect 
All complexation attempts with 73 were carried out in either water or 
methanol with the addition of an external inorganic base such as sodium 
bicarbonate. The choice of these polar protic solvents was dictated by he solubility 
of tripod 73 and all reactions led to the formation of insoluble amorphous solids 
which could not be redissolved. This behavior was observed with all the following 
metal salts: FeCl2·6H2O, Fe(acac)3, Fe(NO3)3·9H2O, CuCN, Cu(acetate)2·H2O, 
Cu(CH3CN)4PF6, Zn(OTf)2. As a general rule the precipitation of solid products 
presumed to be oligomers with bridging imidazolates and carboxylates lways 
appeared after addition of a base. 
 
3.7.2 Synthesis of cobalt (III) complex under neutral conditions 
The metal salts and protonated ligands are soluble and attempts to 
characterize the coordination properties of the ligand was achieved by 
complexation of cobalt (III). For example, the reaction between 73 and CoCl2
.6H2O 
in methanol open to the air led to the isolation of a dark red solid CoIII  complex 
(scheme 3.27), [Co(73)(73-H)]Cl2 104, which was characterized spectroscopically 
by 1H NMR and its structure established by X-ray diffraction (figure 3.3). The 
octahedral geometry about the cobalt atom in 104 is provided by two 2-imidazole-
1-carboxylate subunits of the ligands coordinated in a meridional fashion, with the 
third imidazole of each ligand free to engage in a short (2.68 Å) imidazole-H-
imidazolium hydrogen bond (N23B-H-N23A). The methyl groups of the pendant 
arm are inequivalent and have a chemical shift of δ 1.55 ppm and 1.70 ppm. 
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Moreover three signals are found for the imidazole protons: 1) two res nances are 
shifted upfield by the proximal aromatic systems at δ 5.20 ppm (1H) and 6.77 ppm 
(1H) with a coupling constant of J= 2.1 Hz, 2) one broad singlet at δ 6.90 ppm (2H) 
and 3) a singlet at δ 8.17. ppm (1H). Due to their coordination to cobalt (III) all 
three imidazoles are inequivalent and this was reflected in the three different 
resonances detected for the imidazoles NHs. Finally the proton involved in the short 





















Figure 3.3: X-ray ORTEP diagram for the dication of 104 
Selected bond lengths (Å): Co(1)-O(1B)= 1.888(5); Co(1)-N(8A)= 1.895(5); Co(1)-
N(8B)= 1.908(5); Co(1)-N(14A)= 1.910(5). Selected angles (°): O(1B)-Co(1)-




After careful analysis we determined that the ligand itself might not possess 
the correct architecture for an N3O-coordination in an octahedral environment. The 
ligand was initially conceived as a tripod plus a pendant arm (figure 3.4 (a) and 
(b)), but this was not an accurate indication of its coordinating properties. The 
carboxylate functionality of the tether is the strongest coordinative bond in the 
ligand and its strong electrostatic interaction with the positively charged metal most 
likely controls the coordination mode of the ligand. The crystal structu e of the 
cobalt complex seems to indicate a preference for a meridional c ordination with 
one carboxylate and two imidazoles. The preferred coordination mode of the ligand 
is therefore better described as a 2-imidazole-1-carboxylate uni  plus one imidazole 
























Figure 3.4: Binding modes of 73 
In the particular case of the cobalt complex 104 a greater gain in energy is achieved 
by coordinating a second ligand, with little steric repulsion or strain, rather than 
coordinating the third imidazole. As iron and nickel coordinations were considered 
primary goals and the more technical problems encountered (oligomerization) could 
also stem from poor coordination behavior, we turned our attention to designing a 






Compounds 46132, 83142,158, 87143, 88159, 89145, MOM-Cl160, 36161 were prepared by 
known procedures and matched all spectroscopic data available. 
 




Compound 83 (2.00 g, 14.3 mmol) and imidazole (1.94 g, 28.5 mmol, 2.0 
eq.) were dissolved in dry CH2Cl2 (60 mL) and stirred at room temperature, 
TBDMSCl (2.58 g, 17.1 mmol, 1.2 eq.) was then added and left at room 
temperature overnight. The reaction mixture was diluted with EtOAc (100 mL) and 
washed with saturated NaHCO3 (2  25 mL), brine (25 mL) and dried over MgSO4. 
The organic solvents were partially removed by rotary evaporation and a white 
solid precipitated which was filtered to yield compound 84 (3.40 g, 94% yield). 1H 
(300 MHz, CD3OD) δ 6.98 (s, 2H), 3.64 (s, 2H), 1.36 (s, 6H), 0.93 (s, 9H), 0.09 (s, 
6H); 13C (75.5 MHz, CDCl3) δ 154.9, 73.1, 39.7, 26.4, 24.2, 19.2, -5.4; MS (ESI +): 
exact mass calculated for C13H27N2OSi [M + H]




















To a stirred solution of 84 (1.01 g, 4.0 mmol) in dry THF (10 mL) cooled to 
0 °C, NaH (0.64 g 60% dispersion in mineral oil, 16 mmol, 4 eq.) was added 
portion-wise over 30 min and left at room temperature for 30 min. N,N-
dimethylsulfamoyl chloride was then added neat (0.51 mL, 4.8 mmol, 1.2 eq.) and 
the solution was refluxed for 3 h. The reaction was quenched with H2O and ethyl 
acetate was added (50 mL). The organic phase was then washed wit  saturated 
NaHCO3 (2  25 mL), brine (25 mL) and dried over MgSO4. The organic solvents 
were removed under vacuum and the crude material purified by flash column 
chromatography (7 AcOEt: 3 Hexanes) to yield the desired compound as a white 
solid (1.03 g, 60% yield). 1H (300 MHz, CDCl3) δ 7.15 (d, J= 1.5 Hz, 1H), 6.91 (d, 
J= 1.5 Hz, 1H), 3.89 (s, 3H), 2.94 (s, 6H), 1.46 (s, 6H), 0.83 (s, 9H), 0.00 (s, 6H); 










To a cooled solution of Dess-Martin periodinane (0.740 mg, 1.73 mmol) and 
imidazole (0.120 g, 1.73 mmol) in CH2Cl2 (30 mL) 96 (0.700 1.15 mmol, 1 eq.) 
was added in one portion. The reaction mixture was warmed to room temperature 
and left to stir for one h. The reaction was then quenched with saturated N 2S2O3, 
NaHCO3 (20 mL) and Et2O (30 mL) and stirred for 1 h. The solution was then 
washed with saturated NaHCO3 (20 mL). The organic solvent was removed under 
vacuum and the crude residue was purified by flash column chromatography (8 
Hexanes: 2 AcOEt) to yield 90 as a white solid (0.42 g, 60% yield). IR (KBr) 2933, 
2890, 2851, 1671, 1513, 1389, 1169, 980; 1H (300 MHz, CDCl3) δ 7.55 (s, 2H), 
2.92 (s, 12H), 1.04 (s, 18H), 0.44 (s, 12H); 13C (100.6 MHz, CDCl3) δ 171.0, 162.9, 















2-(1H-Imidazol-2-yl)-2-methyl-propionic acid methyl ester 93:
To a solution of hydroxypivalic methyl ester (10.00 g, 75.7 mmol) in 
dichloromethane (150 mL), trichloroisocyanuric (19.38 g, 83.4 mmol, 1.10 eq.) of 
acid was added. The suspension thus obtained was cooled to 0 °C before adding 
TEMPO (150 mg, 0.96 mmol, 0.010 eq.). The reaction mixture was stirred at 0 °C 
for 15 min before being warmed to room temperature and stirred for 3.5 h. The 
suspension was then filtered through celite and subsequently washed wit  saturated 
Na2CO3 (100 mL), 1N HCl and brine respectively. The organic layer was then dri d 
over MgSO4 and the solvent removed under vacuum. The crude mixture was 
dissolved in methanol (60 mL) and cooled to 0 °C. Concentrated aqueous ammonia 
(16 mL) was added at 0 °C and the solution was stirred for 30 min at room 
temperature. A solution of aqueous glyoxal (40 wt % in H2O, 10.98 g, 75.7 mmol, 1 
eq.) in methanol (20 mL) was added drop-wise over 2.5 h. The reaction was left at 
room temperature overnight. The methanol was then evaporated under reduced 
pressure and the remaining solution was dissolved in warm ethyl acetate (200 mL). 
The organic phase was washed with brine (3  20 mL) and dried over MgSO4. 
Upon evaporation of the solvent an off white solid precipitates which was filtered to 
yield the desired product (7.98 g, 63% yield). Melting point: 148-150 °C; IR (KBr) 
3439, 3115, 2956, 1887, 1729, 1555, 1453, 1374, 1262, 1196, 1162, 1104, 903, 
768; 1H (300 MHz, CDCl3) δ 6.99 (s, 2H), 3.72 (s, 3H), 1.66 (s, 6H); 
13C (75.5 
MHz, CDCl3) δ 176.2, 149.6, 122.0, 52.8, 43.9, 25.9; HRMS (ESI +): exact mass 
calculated for C8H13N2O2 [M + H]











2-(1-Dimethylsulfamoyl-1H-imidazol-2-yl)-2-methyl-propionic acid methyl ester 
94: 
To a solution of 2-(1H-imidazol-2-yl)-2-methyl-propionic acid methyl ester 
93 (5.00 g, 29.7 mmol) in dry THF (150 mL) cooled to 0 °C, NaH (1.80 g, 60% 
dispersion in mineral oil, 45 mmol, 1.5 eq.) was added portion-wise over 30 min. 
and left stirring at room temperature for 30 min. N,N-dimethylsulfamoyl chloride 
was then added neat (3.8 mL, 35 mmol, 1.2 eq.) and the solution was refluxed for 3 
h. The reaction was quenched with H2O and ethyl acetate was added (150 mL). The 
organic layer was then washed with saturated NaHCO3 (2  25 mL), brine (25 mL) 
and dried over MgSO4. The organic solvents were removed at reduced pressure and 
the crude purified by flash column chromatography (75 AcOEt: 25 Hexanes) to 
yield the desired compound as a white solid (4.91 g, 60% yield). Melting point: 83-
85 °C; IR (KBr) 3154, 2992, 1742, 1536, 1491, 1380, 1281, 1262, 1097, 981; 1H 
(300 MHz, CDCl3) δ 7.11 (d, J= 1.5 Hz, 1H), 7.01 (d, J= 1.5 Hz, 1H), 3.70 (s, 3H), 
2.90 (s, 6H), 1.71 (s, 6H); 13C (75.5 MHz, CDCl3) δ 175.6, 152.1, 127.8, 118.5, 
52.4, 45.8, 38.4, 26.5; HRMS (ESI +): exact mass calculated for C10H17N3O4S [M + 













3-N,N-Dimethylsulfamoyl-3H-imidazole-4-carboxylic acid dimethylamide 95 
To a stirred solution of 47 (1.00 g, 3.45 mmol, 1 eq.) in THF (120 mL) at -
78 °C under a positive pressure of Ar, BuLi in pentane (2.0 mL, 1.90 M, 1.1 eq.) 
was added drop-wise. The solution was left 30 min at -78 °C before ClCONMe2 
(0.155 mL, 1.69 mmol, 0.5 eq.) was added neat. The reaction was warmed to room 
temperature and left stirring overnight. The mixture was then quenched with 
saturated NaHCO3 and ethyl acetate (30 mL) was added. The organic phase was 
washed with saturated NaHCO3 (2  25 mL), brine (25 mL) and dried over MgSO4. 
The organic solvent was removed under vacuum and the crude product was 
analyzed by 1H NMR spectroscopy. In order to confirm the assignment 100 mg of 
crude product was purified by preparative TLC (1 Hexanes: 1 AcOEt) to yield of 
the desired product as a white solid (20 mg) along with the starting material 47. 1H 
(300 MHz, CDCl3) δ 7.28 (d, J= 1.5 Hz, 1H), 7.07 (d, J= 1.8 Hz, 1H), 3.10 (s, 3H), 
3.00 (s, 6H), 2.91 (s, 3H); MS (ESI +): exact mass calculated for C15H32N4O3SSiNa 







To a stirred solution of sulfonamide 47 (1.807 g, 10.3 mmol) in anhydrous 
THF (90 mL) at -78 °C under a positive pressure of Ar, BuLi in pentane (5.4 mL, 
2.10M, 11 mmol, 1.1 eq.) was added drop-wise. The solution was left 30 min at-78 
°C before TBDMSCl (1.86 g, 12.4 mmol 1.2 eq.) dissolved in THF (2 mL) was 
cannulated in the reaction mixture. The reaction mixture was then warmed to room 
temperature and left to stir for 3 h. The reaction was cooled back down to -78 °C 
and ethylformate (415 µL, 5.20 mmol, 0.5 eq) was added neat. The reaction was 
slowly warmed to room temperature overnight. The mixture was then queched 
with saturated NaHCO3 and ethyl acetate (100 mL) is added. The organic layer was 
washed with saturated NaHCO3 (2  50 mL), brine (50 mL) and dried over MgSO4. 
The organic solvent was removed under vacuum and the crude was purified by 
flash column chromatography (9 CH2Cl2: 1 Acetone) to yield the desired product as 
a white solid (1.60 g, 51% yield). The compound matched the reported 
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spectroscopic data: 1H (300 MHz, CDCl3) δ 7.07 (d, 2H, J= 0.6 Hz), 6.53 (d, 1H, 
J= 3.6 Hz), 3.58 (d, 1H, J= 3.6 Hz), 2.81 (s, 6H), 1.01 (s, 18H), 0.43 (s, 6H), 0.43 





methoxymethyl-1H-imidazol-2-yl}-2-methyl-propionic acid methyl est r 97: 
1-N,N-dimethylsulfamoyl-imidazole 47 (800 mg, 4.6 mmol, 1 eq.) was 
dissolved in dry THF (45 mL) and stirred under a positive pressure of Ar. The 
temperature was lowered to -78 °C and a solution of -BuLi in pentane (5.1 mmol, 
2.8 mL of a 1.81 M solution, 1.1 eq.) was added drop-wise. After stirring for 30 
min, a solution of 100 (617 mg, 2.3 mmol, 0.5 eq.) in dry THF (5 mL) was added 
via cannula. The reaction was then left overnight to slowly warm up to room 
temperature. EtOAc (50 ml) was added and the organic phase was washed with of 
saturated NaHCO3 (2  30 mL), brine (30 mL) and dried over MgSO4. The organic 
solvents were removed under vacuum and the crude was purified by flash column 
chromatography (95 CH2Cl2: 5 MeOH) to yield product 97 as a white solid (0.99 g, 
74% yield). Melting point: decomposes at 60-65 °C; IR (KBr) 3439, 3122, 2941, 
1737, 1389, 1266, 1177, 1153, 980; 1H (300 MHz, CDCl3) δ 7.30 (d, J= 1.5 Hz, 
2H), 7.92 (d, J= 1.5 Hz, 2H), 6.54 (s, 1H), 5.76 (s, 1H), 5.06 (s, 2H), 3.66 (s, 3H), 
3.19 (s, 3H), 2.95 (s, 6H), 1.68 (s, 6H); 13C (75.5 MHz, CDCl3) δ 175.9, 150.4, 
147.9, 139.3, 126.4, 121.9, 119.8, 77.7, 73.1, 56.2, 52.6, 44.1, 38.5, 25.9; HRMS 
(ESI +): exact mass calculated for C21H32N8O8S2Na [M + Na]
















carboxylic acid methyl ester 98: 
To a stirred solution of 94 (4.00 g, 14.5 mmol) in of THF (120 mL) at -78 
°C under a positive pressure of Ar, BuLi in pentane (16.0 mmol, 9.7 mL, 1.65M, 
1.1 eq.) was added drop-wise. The solution was left 30 min at -78 °C before methyl 
chloroformate (2.3 mL, 30 mmol, 2.1 eq.) was added neat. The reaction was 
warmed to room temperature and left stirring for 2 h. The mixture was then 
quenched with saturated NaHCO3 and ethyl acetate (100 mL) was added. The 
organic phase was washed with saturated NaHCO3 (2  50 mL), brine (50 mL) and 
dried over MgSO4. The organic solvent was removed under vacuum and the crude 
was purified by flash column chromatography (9 CH2 l2: 1 AcOEt) to yield the 
desired product as a white solid (4.65 g, 96% yield). Melting point: 92-95 °C; IR 
(KBr) 3003, 2956, 1745, 1490, 1386, 1262, 1200, 1154, 980; 1H (300 MHz, CDCl3) 
δ 7.61 (s, 1H), 3.86 (s, 3H), 3.70 (s, 3H), 2.90 (s, 6H), 1.73 (s, 6H); 13C (75.5 MHz, 
CDCl3) δ 175.1, 158.8, 158.6, 136.8, 124.9, 118.5, 52.3, 52.3, 47.4, 38.3, 27.0; 













2-(1-Methoxycarbonyl-1-methyl-ethyl)-3H-imidazole-4-carboxylic acid methyl 
ester 99: 
To a cooled solution of 98 (4.55 g, 13.6 mmol) in dry methanol (120 mL), 
concentrated H2SO4 (1 mL) was added and the solution was refluxed for 20 h. The 
solution was then cooled to room temperature and 1N NaOH (40 mL) was added. 
The aqueous layer was extracted with CH2 l2 (3  100 mL) Removal of the 
organic solvent yielded compound 99 in a pure form as a white solid (2.61 g, 85% 
yield). Melting point: 148-149 °C; IR (KBr) 3003, 2956, 1741, 1725, 1528, 1443, 
1347, 1262, 1200, 1169, 1108; 1H (300 MHz, MeOD:TFA (4:1, v:v)) δ 8.07 (s, 
1H), 3.94 (s, 3H), 3.75 (s, 3H), 1.77 (s, 6H); 13C (75.5 MHz, CDCl3) δ 173.4, 159.6, 
152.7, 126.8, 125.3, 54.1, 53.4, 45.4, 24.5;  HRMS (ESI +): exact mass calculated 
for C10H14N2O4Na [M + Na]








carboxylic acid methyl ester 100: 
To a stirred solution of 99 (1.00 g, 3.7 mmol) in THF (60 mL) at 0 °C, NaH 
(60% mineral oil, 220 mg, 5.50 mmol. 1.5 eq.) was added portion-wise and warmed 
to room temperature. MOM-Cl (410 µL, 5.40 mmol, 1.5 eq.) was then added neat 
and the reaction was left stirring overnight. After adding ethyl acetate (50 mL), the 
organic phase was washed with saturated NaHCO3 (2  30 mL), brine (50 mL) and 
dried over MgSO4. The solvents were removed under vacuum and the crude residue 
purified by flash column chromatography (6 AcOEt: 4 Hexanes) to yield the 
desired compound 100 as a white solid (1.08 g, 90% yield). Melting point: 45-46 
°C; IR (KBr) 3138, 2991, 2953, 1737 1552 1509, 1443, 1351, 1270, 1235, 1200, 
1157, 1123, 1092, 1011; 1H (300 MHz, CDCl3) δ 7.69 (s, 1H), 5.11 (s, 2H), 3.87 (s, 
3H), 3.66 (s, 3H), 3.28 (s, 3H), 1.69 (s, 6H); 13C (75.5 MHz, CDCl3) δ 175.5, 163.4, 
150.8, 131.3, 128.0, 56.6, 52.7, 51.9, 44.2, 25.8; HRMS (ESI +): exact mass 
calculated for C12H19N2O5 [M + H]











propionic acid 73: 
A solution of 97 (0.94 g, 1.60 mmol) in 6N HCl (40 mL) was refluxed for 6 
h. The solvent was evaporated under reduced pressure. The crude product was 
loaded onto a column chromatography Dowex 50WX8-100 resin (10 mL) and 
washed with water. The product was eluted with 6% aqueous ammonia. After 
removing almost all the solvent addition of acetone precipitated an off-white solid 
(0.43 g, 85% yield). Melting point: decomposes at 130 °C; IR (KBr) 3458, 3207, 
2983, 1660, 1617, 1567, 1532, 1447, 1404, 1355, 1115, 1077, 1027; 1H (300 MHz, 
CD3OD) δ 7.17 (s, 4H), 6.81 (s, 1H), 5.76 (s, 1H), 1.55 (s, 6H); 13C (75.5 MHz, 
CD3OD) δ 181.1, 155.6, 149.7, 138.7, 122.5, 117.8, 119.8, 71.0, 46.7, 38.5, 26.1; 
HRMS (ESI +): exact mass calculated for C14H17N6O3 [M + H]









Preparation of complex 104: 
To a solution of 73 (100.8 mg, 0.32 mmol) in methanol (5 mL), CoCl2·6H2O 
(38.0 mg, 0.16 mmol; 0.5 eq.) was added. The reaction mixture was left stirring at 
room temperature for 2 h. The solution was then concentrated and left to slowly 
evaporate open in the air, which yielded crystals suitable for X-ray analysis. The 
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red crystals were washed with acetone and dried under vacuum. Melting poi t: 
decomposes at 195-200 °C; IR (KBr) 3425, 3146, 3003, 2933, 1591, 1477, 1405, 
1378, 1351, 1119, 1088, 1061, 889, 772; 1H (300 MHz, DMSO-d6, 65 °C) δ 13.86 
(bs, 2H), 13.35 (bs, 2H), 8.27 (s, 2H), 8.17 (bs, 2H), 6.90 (bs, 4H), 6.77 (d, J 1.8 
Hz, 2H), 5.20 (d, J= 2.1 Hz, 2H), 1.70 (s, 6H), 1.55(s, 6H); MS (ESI +): exact mass 
calculated for C28H30N12O6Co [M - H]
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Table 3.4: Crystal data and structure refinement for 104 
Empirical formula C29 H45 Cl2 Co N12 O12 
Formula weight 883.60 
Crystal system Triclinic 
Space group P1 
Unit cell dimensions a= 12.381(12) Å, α= 72.897(9)° 
b= 12.735(12) Å, β= 69.379(11)° 
c= 15.117(14) Å, γ= 67.594(11)° 
Volume 2027(3) Å3 
Z, Z' 2, 1 
Density (calculated) 1.448 Mg/m3 
Wavelength 0.71073 Å 
Temperature 100(2) K 
F(000) 920 
Absorption coefficient 0.627 mm-1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.959 and 0.832 
Theta range for data collection 2.02 to 26.00° 
Reflections collected 19401 
Independent reflections 7901 [R(int)= 0.1622] 
Data / restraints / parameters 7901 / 1 / 524 
wR(F2 all data) wR2= 0.2609 
R(F obsd data) R1= 0.0864 
Goodness-of-fit on F2 1.014 
Observed data [I > 2σ(I)] 4537 
Largest and mean shift / s.u. 0.000and 0.000 
Largest diff. peak and hole 1.364 and -1.040 e/Å3 
wR2= { Σ [w(Fo2 - Fc2)2] / Σ [w(Fo 2)2] } 1/2  





The DFT calculations were performed using Becke’s three parameter hybrid 
functional with the correlation of Lee, Yang and Parr (B3LYP)162-165. The 
geometries were calculated with the 6-31+G(d) basis set and a single point was 
performed on 98 and 100 with an augmented basis set 6-311+G(d,p). 
 
Addition attempt of 85 to 87-89 (scheme 3.9) 
The protected imidazole 85 (800 mg, 2.21 mmol, 1 eq.) was dissolved in dry 
THF (45 mL) under a positive pressure of Ar. The temperature was lowered to -78 
°C and a solution of n-BuLi in pentane (2.43 mmol, 1.4 mL of a 1.80 M solution, 
1.1 eq.) was added drop-wise. After stirring for 30 min, a solution of 87 (418 mg, 
2.20 mmol, 1 eq.) in dry THF (5 mL) was added via cannula. The reaction was then 
left overnight to slowly warm up to room temperature. EtOAc (50 ml) was added 
and the organic phase was washed with saturated NaHCO3 (2  30 mL), brine (30 
mL) and dried over MgSO4. The organic solvents were removed under vacuum. 
The crude mixture was analyzed by TLC and 1H NMR spectroscopy and only 
starting material 87 was detected with numerous by-products. Procedures for 88 
and 89 were carried out in a similar way. 
 
Addition attempt of 94 to 90 (scheme 3.18) 
The ester 94 (502 mg, 1.82 mmol, 1 eq.) was dissolved in dry THF (50 mL) 
under a positive pressure of Ar. The temperature was lowered to -78 °C and a 
solution of n-BuLi in pentane (2.00 mmol, 1.0 mL of a 1.92 M solution, 1.1 eq.) 
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was added drop-wise. After stirring for 30 min, a solution of 90 (907 mg, 1.80 
mmol, 1 eq.) in dry THF (5 mL) was added via cannula. The reaction was then left 
overnight to slowly warm up to room temperature. EtOAc (100 ml) was added and 
the organic phase was washed with saturated NaHCO3 (2  30 mL), brine (30 mL) 
and dried over MgSO4. The organic solvents were removed under vacuum. The 
crude mixture was analyzed by TLC and 1H NMR spectroscopy and only starting 
materials 94 and 90 without any by-product. 
 
Addition attempts of 47 and 46 to 98 (scheme 3.21) 
1-N,N-dimethylsulfamoyl-imidazole 47 (300 mg, 1.71 mmol, 1 eq.) was 
dissolved in dry THF (45 mL) under a positive pressure of Ar. The temperature was 
lowered to -78 °C and a solution of n-BuLi in pentane (1.71 mmol, 0.86 mL of a 
1.98 M solution, 1.1 eq.) was added drop-wise. After stirring for 30 min, a solution 
of 98 (569 mg, 1.71 mmol, 1 eq.) in dry THF (3 mL) was added via cannula. The 
reaction was then left overnight to slowly warm up to room temperature. EtOAc (30 
ml) was added and the organic phase was washed with saturated NaHCO3 (2  20 
mL), brine (20 mL) and dried over MgSO4. The organic solvents were removed 
under vacuum. The crude mixture was analyzed by TLC and 1H NMR spectroscopy 
and only starting material 47 was detected with numerous by-products. The 






Addition attempts of 36 and 101-103 to 100 (scheme 3.23): 
1-Methoxymethyl-1H-imidazole 36 (83 mg, 0.74 mmol, 1 eq.) was 
dissolved in dry THF (10 mL) under a positive pressure of Ar. The temperature was 
lowered to -78 °C and a solution of n-BuLi in pentane (0.74 mmol, 0.42 mL of a 
1.78 M solution, 1.1 eq.) was added drop-wise. After stirring for 30 min, a solution 
of 100 (100 mg, 0.37 mmol, 0.5 eq.) in dry THF (1 mL) was added via cannula. The 
reaction was then left overnight to slowly warm up to room temperature. EtOAc (10 
ml) was added and the organic phase was washed with saturated NaHCO3 (2  10 
mL), brine (10 mL) and dried over MgSO4. The organic solvents were removed 
under vacuum. The crude mixture was analyzed by TLC and 1H NMR spectroscopy 
and only starting material 36 was detected with numerous by-products. The 
procedures for 46, 101-103 were carried out in a similar way and yielded the same 
result: recovery of the pro-nucleophiles and consumption of the electrophile 100. 
 
Complexation experiments of 73: 
 The short side-chain tripod 73 (50 mg, 0.16 mmol, 1 eq.) was dissolved in 
MeOH (3 mL) and 1 equivalent of metal salt is added. After stirring for 15 min the 
NaHCO3 (15 mg,0.20 mmol , 1.2eq) was added and a precipitate formed. Attempts 
to redisolve it in organic solvents failed. Metal salts used: FeCl2·6H2O, Fe(acac)3, 






Synthesis of the Carboxylate-Functionalized Tris[4-(N-Methyl-2-














4.1 Introduction: Ligand design and retrosynthesis 
As concluded in the previous chapter, 73 behaved as a tridentate ligand 
(meridional coordination) rather than the desired tetradentate N3O-donor and should 
be considered, in terms of its coordination mode, as a 2-imidazole-1-carboxylate 
unit plus one (non-coordinating) imidazole. Careful analysis of the 2-imidazole-1-
carboxylate unit revealed important geometric details of the structure (Scheme 4.1). 
Chelate rings A and B, respectively 6 and 5 membered rings, possess four carbon 
and two nitrogen atoms sp2 hybridized, enforcing two nearly planar rings. In order 
to bring the remaining imidazole in closer proximity to the metal center, to enable 














The first was to extend the linker between the third imidazole and the central 
carbon (scheme 4.2). Though very attractive this option was deemed more ti e 
consuming to achieve since a new methodology for the synthesis of the ligand 















The second plan considered a chain extension of the tether (scheme 4.3). This type 
of modification could enforce a facial coordination of the 2-imidazole-1-
carboxylate unit as an extra methylene group has to be accommodated, thus forcing 














This analysis was supported by PM3 modeling of putative neutral iron (III) metal 
neutral complexes with two chloride ions and either ligand 73 (short side chain, 
figure 4.1) or 106 (extended side chain, figure 4.2). 
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Figure 4.1: Side and top views of the PM3-minimized structure of 73·FeCl2 
Selected dihedral angle (°): C2-N1-C3-C5= -164.4; C1-N2-C3-C5= 163.4 
 
   
Figure 4.2: Side and top views of the PM3-minimized structure of 106·FeCl2 
Selected dihedral angle (°): C2-N1-C3-C26= -177.6; C1-N2-C3-C26= 177.0
 
After geometry minimization of the model complexes, the dihedral angles of the 
complexed ligands were analyzed. The short side chain ligand 73 seemed to display 
considerable ruffling of the imidazole ring bearing the carboxylate, with C5 being 
almost 16° out of the plane of the imidazole ring. This ruffling was much less 
pronounced with the newly proposed ligand 106, as C26 was only 3° out the plane 
of the imidazole ring. This more acceptable dihedral angle should alleviate some of 
the strain and allow for its N3O-coordination in an octahedral environment. 
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Moreover, this strategy has the advantage of capitalizing on the previously 
successful synthesis used and, provided that the added methylene group is 
sufficiently impervious to the basic conditions, minor changes in the synthetic plan 
were expected. Analogous to the preceding route the following retrosynthetic path 
from 106 was devised (scheme 4.4), with the critical step being the formati n of 































4.2 Synthesis of the tripod 81 with an extended side-chain 
4.2.1 Synthesis of 108 by analogy 
The initial approach to the diester 108 was envisioned by simple 















The preparation of the known aldehyde-ester 110 was carried out in two steps from 
methyl isobutyrate. Deprotonation by one equivalent of LDA followed by addition 
of allyl bromide gave the alkene 109 in good yields (80%). The product was 
submitted to ozonolysis and followed by a reduction with triphenylphosphine to 
give 110 in 60% yield.166 
The condensation of the aldehyde with glyoxal and ammonium carbonate on 
gram scale produced the expected imidazole167,168 111 which was purified by 
recrystallization (scheme 4.6.1) in 64 % yield. The structure of prduct 111 was 
confirmed by 1H NMR spectroscopy which displayed all the expected singlets at δ 
6.92 ppm (2H), 3.66 ppm (3H), 2.96 ppm (2H), 1.20 ppm (6H), and was further 
characterized by 13C NMR. Ester 111 was then protected with N,N-dimethyl 
sufamoyl chloride under the usual conditions and purified by flash column 
chromatography yielding 112 in 93% yield (scheme 4.6.2). The side-chain 
extension facilitated the protection step by decreasing the steric crowding from the 
geminal dimethyl unit and the protected imidazole was characterized by 1H NMR 
spectroscopy. The diagnostic appearance of two aromatic doublets at δ 7.12 ppm 
and 6.87 ppm with a coupling constant J= 1.5 Hz indicated the successful addition 
of the protecting group. This was further confirmed by the resonance of dimethyl 
























Unfortunately, as feared, the lithiation of the protected imidzole 112 did not 
occur with the desired selectivity (scheme 4.7). When treated with one equivalent 
of BuLi and methyl chloroformate, the starting material was recovered along with 
numerous by-products after aqueous workup. In order to prevent the presumed 
deprotonation of the added methylene group we turned our attention to tBuLi, a 















However the added bulk was not sufficient to prevent side reactions and only partial 
conversion of 112 was achieved to yield 113 along with numerous unidentified by-
products which rendered its purification difficult (scheme 4.8). Enough was isolated 
to be hydrolyzed and without purification to be protected by ethoxymethyl chloride 
(EOM-Cl) in a 15% overall yield. The protected diester 108 was carefully purified 
by chromatography and characterized by its 1H NMR spectrum which displayed the 
































4.2.2 Modified and improved synthesis of 108 
Given the difficulty in introducing the second carboxyl group on the C5 
position, we considered the possibility of introducing it further upstream before the 
condensation of the imidazole nucleus. The tri-carbonyl compound 116169 (scheme 
4.9), which contains formyl, a keto and a carboxyl group on three adjacent carbons, 
has been reported169 and its interesting reactivity properties exploited. We therefore 




















The addition of diazomethane to ethyl chlorooxoacetate 114 led in moderate yield 
(≈40%) to the diazo compound 115170. Its oxidation by a solution of 




nitrogen gas as the only by-products. This feature allowed us to form the tri-
carbonyl compound 116 in situ and without further purification used it directly in 
the subsequent condensation step with ammonium carbonate167,168 and the aldehyde 

















The imidazole 117 was thus obtained in 56% yield and characterized by 1H NMR 
spectroscopy and mass spectrometry. Interestingly in deuterated chloroform two 
isomers were detected in an approximate ratio of 6:1, with two sets of resonances 
(scheme 4.11). Two aromatic protons were observed at δ 7.63 ppm with a coupling 
constant of J= 2.7 Hz and at δ 7.57 ppm, with a coupling constant of J= 1.8 Hz; the 




















4.2.3 Addition of 47 to 108 and synthesis of the desired target 106
With our new starting materials in hand, the addition reaction of lithiated 47 
to 108 was carried out and successfully produced the desired tripod with an 
extended chain 107, though its complete purification on silica gel was not possible 

























The crude product 107 was therefore used without purification and successfully 
deprotected by acidic hydrolysis, in refluxing 6N HCl for 6hours, to 106. The 
compound was obtained in its neutral form after purification by cation exchange 
chromatography with NH4OH in 27% yield from 47 (scheme 4.13). The product 


























We successfully developed a second synthesis of a 3-imidazole-1-
carboxylate tetrad in six linear steps with an extended side chain. This new ligand 
106 was specifically designed to serve as an N3O-donor in an octahedral 
environment and its coordinating properties were tested. 
 
4.3 Complexation studies and lessons learned 
In order to probe the binding capabilities of 106 different metal salts were 
used. However, very disappointingly all experiments carried out with 
Fe(OTf)2(CH3CN)2
171, Ni(acac)2·2H2O and CoCl2·6H2O failed to provide tractable 
mononuclear complexes (scheme 4.14). As previously observed the addition of any 
type of base (N,N-diisopropylethylamine with iron (II), acac with Ni (II) and 
NaHCO3 with the cobalt (II)) led to the formation of intractable and insoluble 



















Similar behaviors observed with the short or the extended chain pointed to other 
problems imbedded within the ligands themselves. It clearly appeared that more 
dramatic changes of the ligands would be necessary if any characterizable 
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mononuclear complexes were to be produced. We therefore identified all the 
common features of 73 (short side arm) and 106 (long side-arm) potentially 
responsible for the formation of intractable solids and decided to incorporate in our 
last attempt all preemptive measures possible. After careful consideration of the 
previous results, three specific points were targeted. First, the insolubility of the 
ligands in polar aprotic organic solvents greatly limited their use and our ability to 
easily purify them. Secondly, the presence of the N-Hs in the ligands was 
potentially detrimental to the discrete nature of the desired products. Upon binding 
to metal ions a depressed pKa of the imidazole NH120 could potentially lead to 
bridging imidazolate ligands172 and therefore oligomerization. Third, we also were 
aware of the potential unwanted coordination to metal ions by the hydroxo g oup of 
the carbinol; as its coordination for example with copper (II) in similar ligands is 
well documented.173,174 
 
4.4 Synthesis of the carboxylate-functionalized tris[4-(N-methyl-
2-isopropyl-imidazolyl]methane 
4.4.1 Design and retrosynthesis of an optimal ligand for a structural 
model of the 3-His-1-carboxylate motif 
In order to prevent side reactions which could derive from the identified 
shortcomings of the ligands, an optimal design was proposed (figure 4.3 (a) and 
(b)). Protection of all N-Hs was envisioned with an alkyl group, which should 
prevent oligomerization and also improve the solubility of the ligands. Moreover 
introduction of steric bulk with an isopropyl unit at the C2 position should favor the 
formation of discrete 1:1 complexes and also further improve the solubility of the 
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tripods. Last, the deoxygenation of the hydroxy group, result from the addition 
reaction, would leave our ligands with only the required hetero-atoms f r the 
coordination chemistry. We believed that these pre-emptive measures would 

















(a) (b)  
Figure 4.3: New design of the N3O-donor ligand 
 
This new design (scheme 4.15.1) was not without challenges as the 
chemistry used until now had to be extended to new building blocks. A recent 
report175 on the synthesis of a new sterically hindered tris(imidazolyl)carbinol led 
us to consider a modified version of our synthetic approach by the utilization of (4)-
iodo-imidazoles 97 and 98 as pro-nucleophiles (scheme 4.15.2). Given the changes 
proposed, we decided to focus first on the short side chain parent compound as the 

























































The target could again be obtained by two paths already well explor d. Route A 
would use the addition of (4)-iodo-imidazole 120 to the symmetrical ketone of 
imidazoles 119. Route B would utilize the successful disconnect previously used in 
the synthesis of 106 and, as such, we decided it to be our best option. 
 
4.4.2 Synthesis of the optimal ligand 105 
4.4.2.1) Synthesis of 4-iodo-N-methylimidazole 121 
As organomagnesium reagents are known to be less reducing than 
organolithiums, they should also be less prone to single electron transfer. This is 
indeed partially verified as they were used by of Collman122 and Fujii175. The pro-
nucleophile necessary for our purpose must incorporate the iodine atom at he 4-
position in order to produce a chelating tripod 105. Its preparation175,176 was 
achieved by a known procedure (scheme 4.16) starting from imidazole 123 which 
was initially per-iodinated (124) and subsequently reduced back to the mono-



















123 124 125  
Scheme 4.16 
 
The protection of iodo imidazole 125 by MeI gave two regioisomers in 
approximately equal amount (scheme 4.17) in an 82% yield. Fortunately, the 
undesired regioisomer 126 can be isomerized176 to the desired 4-iodo-N-methyl 



















4.4.2.2 Synthesis of the imidazole diester 122
The synthesis of 122 was achieved from a common intermediate, 99, from 
the previous method (scheme 3.22) using sodium hydride and iodomethane (scheme 
4.18). The reaction proceeded as expected producing a fully characterized white 
solid. The five expected 1H NMR resonances were detected as singlets and the 
structure was confirmed by 13C NMR. The regioselectivity of the protection was 
determined by a NOESY experiment and supported the C4 substitution. The 
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germinal dimethyl unit and the aromatic proton resonance were enhanced when the 















Figure 4.4: NOESY experiment on 122 
 
 
4.4.2.3 Addition of 121 to 122 
With our two building blocks readily synthesized, we probed the addition of 
Grignard reagents to the diesters 100 and 122. Initial attempts to use trityl-protected 
intermediate 44 were not successful when metallated with butylmagnesium chloride 
(scheme 4.19). The de-iodinated imidazole trityl-protected 44 and its electrophilic 
partner were both recovered and the desired product was not detected by 1H NMR 




























However, since the chloride derivative is not the commonly used 
nucleophile, we therefore used ethyl magnesium bromide to perform the metal 
halogen exchange. The formation of the Grignard occurred smoothly at room 
temperature but the addition of the electrophilic partner 122 to the Grignard 




























After a great amount of time spent on purification the imidazole-cntaining 
products, they were tentatively assigned as atropoisomers by 1H NMR spectroscopy 
which showed three sets of resonances all consistent with structure 118 (scheme 
4.20). Unfortunately, they could not be separated from each other and even though
the compound was not homogeneous, complexation of the mixture with tetrakis 
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Crystals obtained from a concentrated solution in methanol (figure 4.5) allowed us 
to isolate the copper complex 127. The unrefined crystal structure clearly indicated 
the anticipated coordination of the alkoxy group of the tripod bridging two copper 
centers. Moreover, the syn relation of the three nitrogen-donor atoms t the 
hydroxy group in the crystallized atroposiomer was evidence of the undesired 
geometry of the ligand. 
 




The protection of the hydroxy by a methoxy group, a common tactic used to 
prevent its coordination, seemed to be a poor option as the mixture of 
atropoisomers could remain and most likely give low yields of the desired 
atropoisomer. The reduction of the carbinol to the hydrocarbon on the other hand 
appeared to be a better option. 
 
4.4.2.4 Reduction of carbinols 118 and synthesis of 105 
Different conditions for the reduction of the carbinol were tested and are 
summarized below (scheme 4.22). Activation of the alcohol by trifluoroacetic 
anhydride proved to be unproductive, but addition of trifluoroacetic acid converted 
all atropoisomers to a single one. This result was determined by 1H NMR analysis 
of the crude mixture. Prior to the addition of trifluoroacetic acid (TFA), three sets 
of two resonances (s, 1H and 2H) in the aromatic region were detcted, 
corresponding to the imidazole protons. These three imidazole-containing products, 
after 20 hours at room temperature in CH2 l2 with 3 equivalents of TFA, converged 
to a single one as indicated by detection of only two singlets by 1H NMR 
spectroscopy. This result suggested the clean and reversible formation of the 
carbocation. Its reduction was attempted with sodium borohydride but did not 
proceed cleanly producing numerous products by 1H NMR analysis of the crude 
mixture. However, complete and clean conversion was achieved with triethylsilane 































The purification of 128 was rather difficult, but could be achieved with an alumina 
column (activity grade II) to give 128 in a good purity, in 53% yield over two steps. 
The orange oil displayed all the required signals by 1H NMR spectroscopy with two 
resonances at δ 6.55 ppm (s, 1H), 6.51 ppm (s, 1H) for the aromatic protons and the 
reduction was indicated by a new proton resonance for the methine group at δ 5.27 
(s, 1H). The tripod was also characterized by 13C NMR. With ester 128 in hand, its 
quantitative hydrolysis in refluxing 6N HCl led to the pure carboxylic acid as a tri-
hydrochloride salt 105 (scheme 4.23). The compound was fully characterized by 1H 
NMR spectroscopy which confirmed the hydrolysis of the ester. The protonated 
state was evidenced by the deshielded signals of the imidazole protons at δ 7.61 
ppm (s, 1H), 7.45 ppm (s, 2H), and the methine proton δ 6.00 ppm (s, 1H). The 
structure of the acid was further established by 13C NMR, mass spectrometry 
(ESI+) and the carboxylic acid group was detected by IR spectroscopy with a broad 




























4.5 Synthesis of a structural model complex of Cu-dependent 2,3-
quercetin dioxygenase 
The newly formed tripod 105, even though a tri-hydrochloride carboxylic 
acid salt, seemed to be stable in air and no particular precautions were taken to 
protect it from moisture. Moreover, the compound proved to be soluble in 
methylene chloride in the presence of an organic base such as triethylamine. These 
observations led us to believe that our analysis of the potential problems with our 
previous ligands were at least partially correct. Acid 105 was used in different 
complexation reactions. As we believed that the mono-anionic short side-chain 
ligand 105 would have a better chance to form 1:1 complexes with a mono-cationi  
metal to access to tetrahedral coordination environment, we chose tetrakis 
(acetonitrile) copper (I) hexafluorophosphate as a metal ion source. Wh n the 
ligand was mixed in methanol with two equivalents of potassium carbonate and 
copper (I), no insoluble compounds were formed (scheme 4.24). The solution was 
exposed to air and turned green. After removing methanol under reduced pressure 
and redisolving the crude products in methylene chloride, the filtered solution was 
left overnight in the freezer to yield green crystals suitable for X-ray 





















This dimer of copper (II) presented a distorted square pyramidal geometry 
around the copper center, with two PF6
- counter ions (not shown). The complex 
displays an expected five coordinate copper (II) center and can directly be 
compared to the active site of 2,3-quercetin dioxygenase (A pergillus japonicus) 
with coordinated quercetin (figure 4.8 and table 4.1 and 4.2). The distances are 
similar with the exception of longer Cu-E73 and apical H68 in the enzyme structure 
than in complex 129. The angles around the copper center are different, especially 
the angles N-Cu-N, as it is probably due to the tripod of imidazoles, better suited 
for a facial coordination in an octahedral environment. 
 









Selected bond lengths and angles of (2,3-quercetin dioxygenase–quercetin) 
complex (2,3-QD·QUE) and of 129 
 
Distances (Å) 2,3-QD·QUE27 Complex 129 
Cu-H66/Cu-N15 (trans to O31) 2.11 (0.03) 2.0409(15) 
Cu-H68/Cu-N1 (apical) 2.12 (0.05) 2.2873(16) 
Cu-E73/Cu-O31 2.28 (0.09) 2.0278(13) 
Cu-H112/Cu-N24 2.05 (0.03) 1.9490(15) 
Cu-quercetin/Cu-O30 2.29 (0.06) 1.9534(13) 
Table 4.1: Selected distances of 2,3-QD· UE and 129 
 
Angles (°) 2,3-QD·QUE Complex 107 
H66-Cu-H68 104(3) 86.40(6) 
H66-CuE73 169(3) 156.62(6) 
H66-Cu-H112 100(2) 86.40(6) 
H68-Cu-E73 86(1) 110.87(5) 
E73-Cu-H112 77(2) 83.91(6) 
Table 4.2: Selected angles of 2,3-QD· UE and 129 
 
However, since each monomer is formally positively charged, we belive that 
displacement of the bridging carboxylate is possible and would provide us with an 
excellent monomeric structural model for the 3-His-1-carboxylate te rad with 
copper (II). Preliminary experiments showed a color change upon addition of two 
equivalents of flavonol, a quercetin model, to a solution of 129 in methylene 
chloride. Further investigations are underway in our laboratory as we believe that 




We have developed an effective synthesis of a short arm tripod chelator in 
nine steps, containing the 4
copper (II). To the best of our knowledge this compund is the first tetradentate 
tripodal ligand incorporating three imidazoles and a carboxylate function. Further 
studies are underway in order to determine the type of coordination, if any, between 
flavanol and complex 
also be examined as
reported complexes will surely have a dramatic effect.
accurate structural model










: Views 2,3-QD·QUE (left) and 129 (right)
-TIC motif, and proved its coordinating properties with 
129. The reactivity and catalytic activity of our complex will 
 the difference of ligand environment with the previously 
 Finally this is the most 
29-38 of copper-dependent quercetin 2,3-
 
 




4.6 Final conclusions and future directions 
During the course of this project we have used, improved and developed 
new chemical transformations on imidazoles. First, we have developed an fficient 
and high yielding synthesis of 4-TIC in a “three pot procedure” (50-55% yield), 
which allowed us to synthesize gram quantities of 4-TIC, a 3-His model. The ease 
of synthesis resulted in the study and characterization of a 1:2 (FeIII :2 (4-TIC)) 
complex by X-ray crystallography. This crystal structure is the first one using the 
more biomimetic tripod of imidazole. Moreover, we have explored the 
functionalization of 4-TIC and were able to selectively deprotect its 2 position 
leading the way to its potential functionalization. We also were abl to protect the 
potentially coordinating hydroxy by a methoxy group relying on a newly 
discovered reactivity of 4-TIC (58). It was shown to be prone to substitution under 
acidic contitions and became of great importance in the synthesis of more 























Moreover we have explored the functionalization of the 2 position on 
imidazole utilizing Itoh’s chemistry and discovered a mechanistically interesting 
rearrangement of activated imidazolines. The imidazolines synthesized, bearing 
electron withdrawing groups on the nitrogen atoms, underwent a ring contra tion to 










The synthesis of two carboxylate-functionalized tripods of imidazoles a so 
brought some new and interesting discoveries. First, we have shown by 
computational studies and confirmed experimental reports that the sulfamoyl 
protecting group modifies dramatically the imidazole reactivity. Indeed, the 
addition of one electron to the sulfamoyl protected imidazole was calculated to be 
thermodynamically favorable contrary to more electron rich MOM-imidazole. 
Moreover, this computational study was further extended to the difficult addition 
reaction of lithio-imidazoles to the ester of imidazole 100. The rationalization of the 
observed narrow scope in competent nucleophiles was based on the ionization 
potential of the lithio-imidazoles. 
Second, we have been able to synthesize a mixed tris(imidazolyl)carbinol 
with a short side-chain 73 and analyze its coordinating properties with cobalt (III). 
However, the ligand only formed intractable solids under basic conditis and 
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formed a 2:1 adduct, (73)(73-H):CoIII , under neutral conditions. The cobalt complex 
104 displayed a preferred meridional coordination which led us to develop and 
synthesize a longer side-chain carbinol 106. The synthetic route capitalized on the 
former approach and underwent only slight modifications and optimizations. 
Regrettably, the two ligands 73 and 106 (scheme 4.27) displayed similar behavior 





















Since, the geometric concerns had been addressed by the longer side-chain, 
we considered the common features which could be responsible for the formation 
of intractable solids and three potential problems were identified: 1) the presence of 
potentially acidic imidazole N-H, especially in the presence of metals, could lead to 
bridging imidazolates 2) the lack of solubility of the ligand in polar aprotic solvents 
and 3) the presence of a hydroxyl group known to coordinate metal ions. These
three specific points were addressed by first providing a methyl protecting group on 
the imidazole removing completely the imidazole N-H and presumably increasing 
the solubility. Addition of steric bulk with an isopropyl unit was carried out in order 
to promote 1:1 complexes and also increase solubility. Last but not least, the 
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hydroxyl group was reduced and the N3O methane 105 derivative thus obtained 







This was demonstrated by the formation and characterization of the first 3-
imidazole-1-carboxylate copper (II) complex, a structural mimic of copper-
dependent 2,3-quercetine dioxygenases. This excellent structural mimic w ll be 
spectroscopically studied and its catalytically activity probed. The synthesis of 
ligand 105 is a first step in the generalization of structurally accurate ligands for the 
3-His-1-carboxylate binding motif. The short side-chain likely to form four or five 



















of the chemistry to long side-chain will allow for a larger set of metal ions in an 
octahedral environment to be coordinated in particular Mn, Fe, Co and Ni. As we 
discussed, the dioxygenases are only a subset of the entire population of enzymes 
utilizing the 3-His-1-carboxylate tetrad, the cupin superfamily for example, and the 
study of their biomimetic complexes and in particular their reactivity should 
provide us with a better understanding of the mechanism considered. Moreover, 
these new complexes should provide us with interesting new catalysts nd therefore 






Compounds 110166, 116169 and 121175 were prepared by the reported procedures. 
 
3-{4-[Hydroxy-bis-(1H-imidazol-2-yl)-methyl]-1H-imidazol-2-yl}-2,2-dimethyl-
propionic acid 106 
To a solution of sulfonamide 47 (0.655 mg, 3.74 mmol, 1 eq.) in THF (40 
mL) at -78 °C under a positive pressure of Ar, BuLi in pentane (1.95 mL, 2.12 M, 
4.13 mmol, 1.1 eq.) was added drop-wise. The solution was left 30 min at -78 °C 
before a solution of 108 (0.560 g, 1.88 mmol, 0.5 eq.) in dry THF (5 mL) was 
transferred via cannula. The reaction was warmed to room temperature and left 
stirring overnight. The mixture was then quenched with saturated NaHCO3 and 
ethyl acetate (50 mL) was added. The organic layer was washed with saturated 
NaHCO3 (2 × 50 mL), brine (50 mL) and dried over MgSO4. The organic solvent 
was removed under vacuum and the crude was purified by flash column 
chromatography (95 CH2Cl2: 5 MeOH) without success. The crude product was 
therefore dissolved in 6N HCl (40 mL) and refluxed for 6 h. The crude product was 
loaded onto an ion exchange column chromatography (Dowex 50WX8-100 resin, 
10 mL) and washed with water. The product was then eluted with 6% aqueous 
ammonia. After removing almost all the solvent addition of acetone precipitated an 
off-white solid (0.167 g, yield: 27% overall). 1H (300 MHz, CD3OD) δ 7.10 (s, 4H), 
6.82 (s, 1H), 3.70 (s, 3H), 2.91 (s, 2H), 1.15 (s, 6H); 13C (75.5 MHz, CD3OD) δ 













methyl ester 108 
To a solution of 112 (4.60 g, 15.9 mmol, 1 eq.) in THF (150 mL) at -78 °C under a 
positive pressure of Ar, tBuLi in pentane (17.4 mmol, 11.2 mL, 1.55M, 1.1 eq.) was 
added drop-wise. The solution was left 1 h at -78 °C before methyl chloroformate 
(2.5 mL, 32.4 mmol, 1.9 eq.) was added neat. The reaction was warmed to room 
temperature and left stirring for 2 h. The organic solvent was remov d under 
reduced pressure and the crude was purified by flash column chromatography (3 
Hexanes: 7 AcOEt) to yield 1.44 g of an impure product. The crude product was 
then submitted to methanolysis by refluxing overnight in methanol (50 mL) with 
concentrated H2SO4 (0.3 mL). The mixture was then quenched with saturated 
NaHCO3 and ethyl acetate (100 mL) was added. The organic layer was washed 
with of saturated NaHCO3 (2  50 mL), brine (50 mL) and dried over MgSO4. 
Once again the crude product (0.97 g) was used and dissolved in dry THF (40 mL) 
cooled to 0 °C. NaH (0.320 g, 8 mmol, 60% dispersion in mineral oil) was added 
portion-wise over 30 min and left at room temperature for 30 min. EOM-Cl was 
then added neat (0.45 mL, 4.8 mmol, 1.2 eq.) and left at room temperature 
overnight. The reaction was quenched with H2O and ethyl acetate was added (50 
mL). The organic phase was washed with saturated NaHCO3 (2  25 mL), brine 
(25 mL) and dried over MgSO4. The organic solvents were removed under reduced 
pressure and the crude product purified by flash column chromatography (7 AcOEt: 
3 Hexanes) to yield the desired compound as a white solid (0.72 g, yield: 15% 
overall). 1H (300 MHz, CDCl3) δ 7.62 (s, 1H, J= 2.7 Hz), 5.30 (s, 2H), 3.86 (s, 3H), 
3.66 (s, 3H), 3.43 (q, J= 6.9 Hz, 2H), 1.32 (s, 6H), 1.17 (t, J= 6.9 Hz, 3H); MS 
(ESI +): exact mass calculated for C14H23N2O5 [M + H]






3-(1H-Imidazol-2-yl)-2,2-dimethyl-propionic acid methyl ester 111: 
To a solution of 2,2-dimethyl-4-oxo-butyric acid methyl ester 6.90 g (47.9 
mmol, 1 eq.) in methanol (40 mL), ammonium carbonate (4.6 g, 47.9 mmol, 1 eq.) 
was added and the solution was stirred for 30 min at room temperature. A solution 
of aqueous glyoxal (40 wt % in H2O, 6.95 g, 47.9 mmol, 1 eq.) in methanol (10 
mL) was added. The reaction was left stirring at room temperatur  overnight. The 
methanol was then removed under reduced pressure and the remaining solution was 
dissolved in warm ethyl acetate (200 mL). The organic phase was washed with 
brine (3  20 mL) and dried over MgSO4. Upon evaporation of the solvent an off 
white solid precipitated which was filtered to yield the desired product (5.60 g 64% 
yield). 1H (300 MHz, CDCl3) δ 6.92 (s, 2H), 3.66 (s, 3H), 2.96 (s, 2H), 1.20 (s, 6H); 














3-(1-Dimethylsulfamoyl-1H-imidazol-2-yl)-2,2-dimethyl-propionic acid methyl 
ester 112: 
To a stirred solution of imidazole 111 (4.60 g, 25.2 mmol, 1 eq.) in dry THF 
(130 mL) cooled to 0 °C, NaH (1.60 g, 40 mmol, 1.6 eq., 60% dispersion in mineral 
oil) was added portion-wise over 30 min and left at room temperature for 30 min. 1-
N,N-dimethylsulfamoyl chloride was then added neat (3.3 mL, 30.7 mmol, 1.2 eq.) 
and left at room temperature overnight. The reaction was quenched with H2O and 
ethyl acetate was added (200 mL). The organic phase was then washed with  of 
saturated NaHCO3 (2 × 50 mL), brine (50 mL) and dried over MgSO4. The organic 
solvents were removed under reduced pressure and the resulting crude product 
purified by flash column chromatography (6 AcOEt: 4 Hexanes) to yield of the 
desired compound as a white solid (6.80 g, 93% yield). 1H (300 MHz, CDCl3) δ 
7.12 (d, J= 1.5 Hz, 1H), 6.87 (d, J= 1.5 Hz, 1H), 3.62 (s, 3H), 2.82 (s, 6H), 1.27 (s, 













2-(2-Methoxycarbonyl-2-methyl-propyl)-3H-imidazole-4-carboxylic acid ethyl 
ester 117: 
A solution of dimethyldioxirane in acetone (0.1 M, 60 mL) was added to 
115 (0.600 g, 4.22 mmol, 1 eq.), after 30 min the solvent was removed under 
reduced pressure and the crude product redissolved in MeOH (25 mL). 2,2-
dimethyl-4-oxo-butyric acid methyl ester 85 (0.608 mg, 4.23 mmol, 1 eq.) and 
ammonium carbonate (0.405 mg, 4.23 mmol, 1 eq.) were added. The solution was 
stirred overnight at room temperature. The methanol was then removed under 
reduced pressure and the resulting crude product purified by flash column 
chromatography (8 AcOEt: 2 Hexanes) to yield of the desired compound as a white 
solid (0.60 g, 56% yield). Major isomer: 1H (300 MHz, CDCl3) δ 7.63 (d, J= 1.5 
Hz, 1H), 7.01 (d, J= 1.5 Hz, 1H), 4.36 (q, J= 7.5 Hz, 2H), 3.73 (s, 3H), 3.03 (s, 2H), 
1.37 (t, J= 6.9 Hz, 3H), 1.23 (s, 6H);MS (ESI +): exact mass calculated for 
C12H18N2O4Na [M + Na]
+ 277.12. Found 27.10. 
 
2-(2-Methoxycarbonyl-2-methyl-propyl)-1-methoxymethyl-1H-imidazole-4-
carboxylic acid ethyl ester 122 
To a solution of 99 (1.70 g, 7.51 mmol) in dry THF (75 mL) cooled to 0 °C, 
NaH (0.45 g, 11.4 mmol, 1.5 eq., 60% dispersion in mineral oil) was added portion-
wise over 30 min and left at room temperature for 30 min and cooled to 0 °C.
Iodomethane was added neat (0.58 mL, 9.0 mmol, 1.2 eq.) and the solution was 
warmed to room temperature overnight. The reaction was quenched with H2O and 
ethyl acetate was added (50 mL). The organic phase was then washed with 
saturated NaHCO3 (2 × 25 mL), brine (25 mL) and dried over MgSO4. The organic 
solvents were removed under vacuum and the resulting crude product purified by 
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flash column chromatography (6 AcOEt: 4 Hexanes) to yield 122 as a white solid 
(1.48 g 82% yield). Melting point: 82-84 °C; IR (KBr) 3129, 3084, 2993, 2956, 
1737, 1704, 1556, 1440, 1346, 1251, 1226, 1012; 1H (300 MHz, CDCl3) δ 7.55 (s, 
1H), 3.87 (s, 3H), 3.71 (s, 3H), 3.53 (s, 3H), 1.69(s, 6H); 13C (75.5 MHz, CDCl3) δ 
175.5, 163.3, 150.6, 130.9, 121.1, 52.7, 51.7, 43.7, 34.1, 25.3; HRMS (ESI +): 
exact mass calculated for C11H16N2O4Na [M + Na]











methyl-propionic acid methyl ester 128 
To a solution of 121 (1.09 g, 4.35 mmol) in CH2Cl2 (20 mL) at room 
temperature under a positive pressure of Ar, EtMgBr in diethyl ether (4.8 mmol, 1.5 
mL, 3.05 M, 1.1 eq.) was added drop-wise. The solution was left 1 h at room 
temperature before 122 (0.500 g, 2.18 mmol, 0.5 eq.) was added in methylene 
chloride (2 mL). The reaction was left stirring for 40 h and then quenched with 
saturated NaHCO3. The organic phase was washed with of saturated NaHCO3 (2  
50 mL), brine (50 mL) and dried over MgSO4. The organic solvent was removed 
under vacuum and to the crude product, redissolved in dichloroethane (20 mL), 
triethylsilane (0.69 mL, 5.36 mmol, 2 eq.) and trifluoroacetic acid (0.48 mL, 6.54 
mmol, 3 eq.) were added. The reaction was refluxed for 20 h. The solvent was 
removed under reduced pressure and redissolved in EtOAc (50 mL). The organic 
phase was then washed with saturated NaHCO3 (2  50 mL), brine (50 mL) and 
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dried over MgSO4. The crude product was purified by alumina chromatography 
activity grade (II) in three phases: 1) (acetone 3: CH2Cl2 7) 2) CH2Cl2 and 3) 
(MeOH 1: 9 CH2Cl2) to yield 0.33 g of an orange oil (yield 53%). 
1H (300 MHz, 
CDCl3) δ 6.55 (s, 1H), 6.51 (s, 1H), 5.27 (s, 1H), 3.69 (s, 3H) 3.49 (s, 6H), 3.36 (s, 
3H), 2.97 (sep, J= 6.9 Hz, 3H), 1.62 (s, 6H), 1.30 (d, J= 7.2 Hz, 12H); 13C (75.5 
MHz, CDCl3) δ 176.6, 151.8, 147.8, 141.5, 141.4, 120.6, 118.3, 52.4, 43.5, 39.0, 














methyl-propionic acid 105 
Ester 128 was dissolved in 6N HCl (20 mL) and the solution refluxed for 2 
h. The solvent was removed under reduced pressure to yield quantitatively the 
desired product 105. Melting point: 82-84 °C; IR (KBr) 3052, 2800, 1741, 1704, 
1654, 1519, 1222, 1181; 1H (300 MHz, CD3OD) δ 7.61 (s, 1H), 7.45 (s, 2H) 6.00 
(s, 1H), 3.85 (s, 6H), 3.82 (s, 3H), 3.49 (sep, J= 6.6 Hz, 3H), 1.79 (s, 6H), 1.44 (dd, 
J1=  6.9 Hz, J2=  1.5 Hz, 12H); 
13C (75.5 MHz, CD3OD) δ 172.8, 153.6, 149.7, 
128.2, 127.8, 125.0, 122.9, 43.7, 35.8, 33.8, 29.8, 25.4, 23.1, 18.3; HRMS (ESI +): 
exact mass calculated for C23H35N6O2 [M + H]
















Synthesis of 129 
To a solution of 105 (49.6 mg, 0.10 mmol, 1 eq.) in MeOH (4 mL), tetrakis 
(acetonitrile) copper hexafluorophosphate (34.5 mg, 0.01 mmol, 1 eq.) and 
potassium carbonate (28.4 mg, 0.21 mmol, 2.3 eq.) were added. The solution was 
exposed to air and turned green. After removing methanol under reduced pressure 
and redisolving the compound in methylene chloride, the filtered solution was left 
overnight in the freezer to yield green crystals suitable for X-ray crystallography; 
after vacuum drying the crystals a powder formed yielding the product (25 mg, 
26% yield). 
We acknowledge and thank Dr. D. Powell for his expertise in determining the 










Table 4.3: Crystal data and structure refinement for 107 
Empirical formula C53 H80 Cl14 Cu2 F12 N12 O4 P2 
Formula weight 1862.61 
Crystal system Triclinic 
Space group P1 
Unit cell dimensions 
a= 12.312(2) Å, α= 72.775(6)° 
b= 12.845(2) Å, β= 85.473(6)° 
c= 12.909(2) Å, γ= 80.076(6)° 
Volume 1919.9(5) Å3 
Z, Z' 1, 1/2 
Density (calculated) 1.611 Mg/m3 
Wavelength 0.71073 Å 
Temperature 100(2) K 
F(000) 948 
Absorption coefficient 1.162 mm-1 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.747 and 0.638 
Theta range for data collection 1.65 to 28.30° 
Reflections collected 26936 
Independent reflections 9526 [R(int)= 0.0338] 
Data / restraints / parameters 9526 / 47 / 543 
wR(F2 all data) wR2= 0.0913 
R(F obsd data) R1= 0.0366 
Goodness-of-fit on F2 1.008 
Observed data [I > 2σ(I)]  7984 
Largest and mean shift / s.u. 0.002and 0.000 
Largest diff. peak and hole 0.601 and -0.378 e/Å3 





Addition attempt of 44 to 100: 
To a solution of 44 (0.872 g, 2.00 mmol, 1 eq.) in CH2Cl2 (40 mL) at room 
temperature under a positive pressure of Ar, BuMgCl in diethyl eter (2.2 mmol, 
1.4 mL, 1.6 M, 1.1 eq.) was added drop-wise. The solution was left 1 h at room 
temperature before 100 (0.271 g, 1.00 mmol, 0.5 eq.) was added in methylene 
chloride (2 mL). The reaction was left stirring for 40 h and then quenched with 
saturated NaHCO3. The organic phase was washed with saturated NaHCO3 (2  50 
mL), of brine (50 mL) and dried over MgSO4. The organic solvent was removed 
under vacuum and the 1H NMR spectrum of the crude mixture showed only starting 
materials. 
 
Complexation experiments of 106: 
 The extended side-chain tripod 106 (50 mg, 0.15 mmol, 1 eq.) was dissolved 
in MeOH (3 mL) and 1 equivalent of metal salt was added. After stirring for 15 min 
the NaHCO3 (15 mg, 0.20 mmol , 1.2eq) was added and a precipite formed. 
Attempts to redisolve it in organic solvents failed. Metal salts u ed: 
Fe(OTf)2(CH3CN)2
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